<?xml version="1.0" encoding="utf-8" ?>

<XML>
  <JOURNAL>   
    <YEAR>2024</YEAR>
    <VOL>16</VOL>
    <NO>1</NO>
    <MOSALSAL>30059</MOSALSAL>
    <PAGE_NO>64</PAGE_NO>  
    <ARTICLES>

<ARTICLE>
    <TitleE>Novel Osteoporosis Therapeutic Targets Derived from Medical Biotechnology</TitleE>
    <TitleF></TitleF>
    <TitleLang_ID>2</TitleLang_ID>
    <ABSTRACTS>

        <ABSTRACT>
            <Language_ID>2</Language_ID>
            <CONTENT>&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Osteoporosis is known as the most prevalent metabolic bone disease. Population aging and increasing life span are making osteoporosis one of the most challenging age-related diseases &lt;/span&gt;&lt;sup&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;1&lt;/span&gt;&lt;/sup&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;. Based on reports in 2009, over 500 million people are struggling with this disease. Also, 1 in 5 men and 1 in 3 women over 50 years suffer from osteoporotic fractures during their lifetime. 1.5 million osteoporotic fractures are occurred annually in the United States and it cost the healthcare system in this country about $57 billion in 2018. The disease is caused by an imbalance in bone homeostasis, which is induced by bone formation not compensating for bone resorption. This process lowers the Bone Mineral Density (BMD) and makes bone susceptible to fracture &lt;/span&gt;&lt;sup&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;2,3&lt;/span&gt;&lt;/sup&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;The significant burden of osteoporosis can be decreased since the disease is treatable. Based on the mechanisms resulting in osteoporosis, two main conventional drug categories are used for the treatment of the disease including anti-resorptive agents and anabolic agents &lt;/span&gt;&lt;sup&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;2&lt;/span&gt;&lt;/sup&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;. Conventional treatments consist of Selective Estrogen-Receptor Modulators (SERMs), bisphosphonates, parathyroid hormone analogs, and calcitonin. The need for more advanced therapies with fewer adverse effects arises from complications such as increasing risk of cardiovascular diseases, gastrointestinal problems, altering blood calcium levels, potential risks for women in estrogen-related therapies, &lt;em&gt;etc&lt;/em&gt;. &lt;/span&gt;&lt;sup&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;4,5&lt;/span&gt;&lt;/sup&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;As mentioned previously, the imbalance of bone metabolism causes osteoporosis. In this dynamic complex process of metabolism which is known as bone remodeling, connection or disruption of each specific intra-cellular or inter-cellular link can cause or treat the disease &lt;/span&gt;&lt;sup&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;6&lt;/span&gt;&lt;/sup&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;. Hence, this fact represents the remarkable role of medical biotechnology in osteoporosis treatment. Medical biotechnology as an upcoming main pillar of health-related science, has grown so fast in the field of treating disease as well as prevention and diagnosis using a variety of novel approaches &lt;/span&gt;&lt;sup&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;7&lt;/span&gt;&lt;/sup&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;. In recent years, biotechnology has introduced some novel therapeutic targets to the medical world to provide more efficient and safe therapies followed by diminishing osteoporosis as a burdensome disease. Monoclonal RANK Ligand (RANKL) antibodies and monoclonal sclerostin antibodies including denosumab, romosozumab, and blosozumab as recently rendered treatments to medicine, have achieved better therapeutic outcomes than conventional treatments &lt;/span&gt;&lt;sup&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;2&lt;/span&gt;&lt;/sup&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;One of the main novel therapeutic targets is microRNA (miRNA)-based treatment. Modified nucleoside oligomers are the most common miRNA inhibitors used for new approaches. Since the clinical transformation of miRNA inhibitors is less difficult than lentivirus transfection, using them to affect the progress of osteoporosis is more feasible. Cathepsin K inhibitors which are involved in bone resorption in addition to remodeling, have been studied in many trials and are being investigated to find a promising one &lt;/span&gt;&lt;sup&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;8&lt;/span&gt;&lt;/sup&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Another innovation is stem cell therapy which is performed with cell sources from Embryonic Stem Cells (ESCs), induced Pluripotent Stem Cells (iPSCs), and Adult Stem Cells (ASCs). Stem cell therapy provides tissue regeneration which in osteoporosis translates to bone formation. Inducing the growth and differentiation of osteoblasts alongside decreasing activity of osteoclasts via cellular crosstalk are the main roles of stem cell therapy &lt;/span&gt;&lt;sup&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;4&lt;/span&gt;&lt;/sup&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;. The Wnt signaling pathway components are recently presented as one of the therapeutic targets. So many clinical trials are being conducted for each component to benefit from the bone mass-maintaining ability of these molecules &lt;/span&gt;&lt;sup&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;9&lt;/span&gt;&lt;/sup&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;. The sphingosine-1-phos-phate (S1P) signaling pathway and leucine zipper motif (APPL1) extracellular signal-regulated kinase 1/2 (ERK1/2) signaling pathway and the Bone Morphogenetic Protein (BMP) signaling pathway are other targets to point out that play roles in osteogenesis, conducting osteogenic differentiation of stem cells, and promoting angiogenesis &lt;/span&gt;&lt;sup&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;5&lt;/span&gt;&lt;/sup&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;. A novel RANKL i-body nominated as ADR3 was introduced with features such as a high affinity for binding to human RANKL (hRANKL) and an ability to tolerate many different physical environments &lt;/span&gt;&lt;sup&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;3&lt;/span&gt;&lt;/sup&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;. Also, integrins as cell-adhesion transmembrane molecules have improved postmenopausal women&amp;rsquo;s BMD and made bone loss reversed &lt;/span&gt;&lt;sup&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;6&lt;/span&gt;&lt;/sup&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;. Furthermore, in recent years &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;light has been shed on the bone-related roles of melatonin. Some of its important effects are bone biological rhythm regulatory effects, bone microenvironment modulation, and osteoporosis treatment &lt;/span&gt;&lt;sup&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;10&lt;/span&gt;&lt;/sup&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Population aging is greatly increasing osteoporosis prevalence and burden thus promoting osteoporosis to become an immense concern for the healthcare system. Hence, researching more effective therapies with fewer side effects has become urgent. Although studies introduced innovative targets as effective therapies, more investigations such as high-quality clinical trials are necessary to provide more evidence proving their efficiency. Despite all the mentioned conventional treatments, innovative targets, and upcoming therapeutic strategies, studying and developing molecular targets with more accurate and detailed mechanisms is indispensable. &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Undoubtedly, cooperation between basic sciences, especially neuroscience and biotechnology, and internal medicine can create a brighter future for the treatment of endocrine diseases &lt;sup&gt;11-14&lt;/sup&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
</CONTENT>
        </ABSTRACT>
    </ABSTRACTS>
    <PAGES>
        <PAGE>
            <FPAGE>1</FPAGE>
            <TPAGE>2</TPAGE>
        </PAGE>
    </PAGES>
    <AUTHORS>
        <AUTHOR>
<Name>Sepideh</Name>
<MidName></MidName>
<Family>Hajivalizadeh </Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical SciencesSchool of Medicine, Tehran University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical SciencesSchool of Medicine, Tehran University of Medical Sciences</University>
</Universities>
<Countries>
<Country>IranIran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Shahin</Name>
<MidName></MidName>
<Family>Akhondzadeh</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization></Organization>
</Organizations>
<Universities>
<University></University>
</Universities>
<Countries>
<Country></Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR>
    </AUTHORS>
    <KEYWORDS>
        <KEYWORD><KeyText>Antibodies</KeyText></KEYWORD><KEYWORD><KeyText>Bone density</KeyText></KEYWORD><KEYWORD><KeyText>Cathepsin K</KeyText></KEYWORD><KEYWORD><KeyText>MicroRNAs</KeyText></KEYWORD><KEYWORD><KeyText>Monoclonal</KeyText></KEYWORD><KEYWORD><KeyText>Osteogenesis</KeyText></KEYWORD><KEYWORD><KeyText>RANK Ligand</KeyText></KEYWORD><KEYWORD><KeyText>Stem cells</KeyText></KEYWORD><KEYWORD><KeyText>Wnt signaling pathway </KeyText></KEYWORD>
    </KEYWORDS>
    <PDFFileName>60559.pdf</PDFFileName>
    <REFRENCES>
        <REFRENCE>
            <REF>S&#246;zen T, &#214;zışık L, Başaran N&#199;. An overview and management of osteoporosis. Eur J Rheumatol 2017 Mar;4(1):46-56.##Jiang Q, Zhang F, Zhu B, Zhang H, Han L, Liu X. Comparative efficacy between monoclonal antibodies and conventional drugs in postmenopausal women with osteoporosis: A network meta-analysis. Ann Palliat Med 2021;10(2):1693-702.##Qiu H, Hosking C, Rothzerg E, Samantha A, Chen K, Kuek V, et al. ADR3, a next generation i-body to human RANKL, inhibits osteoclast formation and bone resorption. J Biol Chem 2023 Feb 1;299(2):102889.##Liang B, Burley G, Lin S, Shi YC. Osteoporosis pathogenesis and treatment: existing and emerging avenues. Cell Mol Biol Lett 2022 Sep 4;27:72.##Zou Z, Liu W, Cao L, Liu Y, He T, Peng S, et al. Advances in the occurrence and biotherapy of osteoporosis. Biochem Soc Trans 2020;48(4):1623-36.##Xu H, Wang W, Liu X, Huang W, Zhu C, Xu Y, et al. Targeting strategies for bone diseases: signaling pathways and clinical studies. Signal Transduct Target Ther 2023 May 17;8(1):202.##Pham PV. Chapter 19 - Medical Biotechnology: Techniques and Applications. In: Barh D, Azevedo V, editors. Omics Technologies and Bio-Engineering [Internet]. Academic Press; 2018 [cited 2023 Nov 12]. p. 449–69.##Pham PV. Chapter 19 - Medical Biotechnology: Techniques and Applications. In: Barh D, Azevedo V, editors. Omics Technologies and Bio-Engineering [Internet]. Academic Press; 2018 [cited 2023 Nov 12]. p. 449–69.##Tonk CH, Shoushrah SH, Babczyk P, El Khaldi-Hansen B, Schulze M, Herten M, et al. Therapeutic treatments for osteoporosis-which combination of pills is the best among the bad? Int J Mol Sci 2022 Jan 26;23(3):1393.##Vlashi R, Zhang X, Wu M, Chen G. Wnt signaling: Essential roles in osteoblast differentiation, bone metabolism and therapeutic implications for bone and skeletal disorders. Genes Dis 2023 Jul 1;10(4):1291-317.##Yang K, Qiu X, Cao L, Qiu S. The role of melatonin in the development of postmenopausal osteoporosis. Front Pharmacol 2022 Oct 7;13:975181. ##Noorbala AA, Akhondzadeh S, Davari-Ashtiani R, Amini-Nooshabadi H. Piracetam in the treatment of schizophrenia: implications for the glutamate hypothesis of schizophrenia. J Clin Pharm Ther 1999;24(5):369-74.##Akhondzadeh S. Hippocampal synaptic plasticity and cognition. J Clin Pharm Ther 1999;24(4):241-8.##Akhondzadeh S. The 5-HT hypothesis of schizophrenia. IDrugs 2001;4(3):295-300.##Kashani L, Eslatmanesh S, Saedi N, Niroomand N, Ebrahimi M, Hosseinian M, et al. Comparison of saffron versus fluoxetine in treatment of mild to moderate postpartum depression: a double-blind, randomized clinical trial. Pharmacopsychiatry 2017;50(2):64-8.##</REF>
        </REFRENCE>
    </REFRENCES>
</ARTICLE>

<ARTICLE>
    <TitleE>One-step and Rapid Identification of SARS-CoV-2 using Real-Time Reverse Transcription Loop-Mediated Isothermal Amplification (RT-LAMP)</TitleE>
    <TitleF></TitleF>
    <TitleLang_ID>2</TitleLang_ID>
    <ABSTRACTS>

        <ABSTRACT>
            <Language_ID>2</Language_ID>
            <CONTENT>&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Background:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; SARS-CoV-2 as the cause of novel coronavirus disease (COVID-19) is a member of the family &lt;em&gt;Coronaviridea&lt;/em&gt; that has generated an emerging global health concern. Controlling and preventing the spread of the disease requires a simple, portable, and rapid diagnostic method. Today, a standard method for detecting SARS-CoV-2 is &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;quantitative real-time reverse transcription PCR, which is time-consuming and needs an advanced device. &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;The aim of this study was to evaluate a faster and more cost-effective field-based testing method at the point of risk. We utilized a one-step RT-LAMP assay and developed, for the first time, a simple and rapid screening detection assay targeting the Envelope (&lt;em&gt;E&lt;/em&gt;) gene, using specific primers. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Methods:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; For this,&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; the total &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;RNA was extracted from respiratory samples of COVID-19&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; infected &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;patients &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;and &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;applied to one-step a &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;RT-LAMP&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; reaction.&lt;/span&gt; &lt;span style=&quot;font-size:10.0pt&quot;&gt;The LAMP products were visualized using green fluorescence (SYBR Green I). Sensitivity testing was conducted using different concentrations of the designed recombinant plasmid (TA-E) as positive control constructs. Additionally, selectivity testing was performed using the influenza H1N1 genome. Finally, the results were compared using with conventional real time RT-PCR. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Results:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; It was shown that the RT-LAMP assay has a sensitivity of approximately 15 &lt;em&gt;ng&lt;/em&gt; for the &lt;em&gt;E&lt;/em&gt; gene of SARS-CoV-2 when using extracted total RNA. Additionally, a sensitivity of 112 &lt;em&gt;pg&lt;/em&gt; was achieved when using an artificially prepared TA-E plasmid. Accordingly, &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;for the detection of &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;SARS-CoV-2 &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;infection,&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; the &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;RT-LAMP had high sensitivity and specificity and also could be an alternative method for real-time RT-PCR.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Conclusion:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; Overall, &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;this method can be used as a portable, rapid, and easy method for detecting &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;SARS-CoV-2 &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;in the field and clinical laboratories.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
</CONTENT>
        </ABSTRACT>
    </ABSTRACTS>
    <PAGES>
        <PAGE>
            <FPAGE>3</FPAGE>
            <TPAGE>8</TPAGE>
        </PAGE>
    </PAGES>
    <AUTHORS>
        <AUTHOR>
<Name>Mohammad</Name>
<MidName></MidName>
<Family>Shoushtari</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Virology, Pasteur Institute of Iran</Organization>
</Organizations>
<Universities>
<University>Department of Virology, Pasteur Institute of Iran</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Mehdi</Name>
<MidName></MidName>
<Family>Zeinoddini</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization></Organization>
</Organizations>
<Universities>
<University></University>
</Universities>
<Countries>
<Country></Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Javad</Name>
<MidName></MidName>
<Family>Fathi</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization></Organization>
</Organizations>
<Universities>
<University></University>
</Universities>
<Countries>
<Country></Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Hani</Name>
<MidName></MidName>
<Family>Keshavarz Alikhani</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR</Organization>
</Organizations>
<Universities>
<University>Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Fatemeh</Name>
<MidName></MidName>
<Family>Shiekhi</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Faculty of Chemistry and Chemical Engineering, Malek Ashtar University of Technology</Organization>
</Organizations>
<Universities>
<University>Faculty of Chemistry and Chemical Engineering, Malek Ashtar University of Technology</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR>
    </AUTHORS>
    <KEYWORDS>
        <KEYWORD><KeyText>COVID-19</KeyText></KEYWORD><KEYWORD><KeyText>Detection</KeyText></KEYWORD><KEYWORD><KeyText>LAMP Assay</KeyText></KEYWORD><KEYWORD><KeyText>Real time PCR</KeyText></KEYWORD><KEYWORD><KeyText>SARS-CoV-2</KeyText></KEYWORD>
    </KEYWORDS>
    <PDFFileName>60560.pdf</PDFFileName>
    <REFRENCES>
        <REFRENCE>
            <REF>Sohrabi C, Alsafi Z, O′ Neill N, Khan M, Kerwan A, Al-Jabir A, et al. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Int J Surg 2020 Apr;76:71-76.##Chen L, Xiong J, Bao L, Shi Y. Convalescent plasma as a potential therapy for COVID-19. Lancet Infec Dis 2020;20(4):398-400.##Burki T. Outbreak of coronavirus disease 2019. Lancet Infec Dis 2020;20(3):292-3.##Peeri NC, Shrestha N, Rahman MS, Zaki R, Tan Z, Bibi S, et al. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? Int J Epidemiol 2020;49(3):717-26.##Sedighimehr N, Fathi J, Hadi N, Rezaeian ZS. Rehabilitation, a necessity in hospitalized and discharged people infected with COVID-19: a narrative review. Physical Therapy Reviews 2021;26(3):202-10.##Branson B, Tavakoli R, Khaledi M, Fathi J, Shafiee SM, Afkhami H, et al. The correlations between epidemiological and clinical characteristics, laboratory tests and CT scan reports in the diagnosis of cases 2019 novel coronavirus pneumonia. A diagnostic accuracy study. Acta Medica Iranica 2021;59(10):578-86.##Liu Z, Xiao X, Wei X, Li J, Yang J, Tan H, et al. Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS‐CoV‐2. J Med Virol 2020;92(6):595-601.##Cascella M, Rajnik M, Aleem A, Dulebohn SC, Di Napoli R. Features, evaluation, and treatment of coronavirus (COVID-19). In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan.##Kannan S, Shaik Syed Ali P, Sheeza A, Hemalatha K. COVID-19 (Novel Coronavirus 2019) - recent trends. Eur Rev Med Pharmacol Sci 2020 Feb;24(4):2006-2011.##Phan T. Genetic diversity and evolution of SARS-CoV-2. Infect Genet Evol 2020;81:104260. ##Corman V, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu D, et al. Detection of 2019 novel coronavirus 1361 (2019-nCoV) by real-time RT-PCR. Euro Surveill 2020 Jan;25(3):2000045.##Tang A, Tong Z-d, Wang H-l, Dai Y-x, Li K-f, Liu J-n, et al. Detection of novel coronavirus by RT-PCR in stool specimen from asymptomatic child, China. Emerg Infect Dis 2020;26(6):1337-9. ##Notomi T, Okayama H, Masubuchi H, Yonekawa T, Watanabe K, Amino N, et al. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res 2000;28(12):E63.##Mori Y, Notomi T. Loop-mediated isothermal amplification (LAMP): a rapid, accurate, and cost-effective diagnostic method for infectious diseases. J Infect Chemother 2009;15(2):62-9. ##Monazah A, Zeinoddini M, Saeeidinia A. Evaluation of a rapid detection for Coxsackievirus B3 using one-step reverse transcription loop-mediated isothermal amplification (RT-LAMP). J Virol Methods 2017;246:27-33.##Zeinoddini M, Monazah A, Saeedinia AR. Comparison between RT-PCR, NASBA and RT-LAMP methods for detection of Coxsackievirus B3. Biomacromol J 2017;3(2):100-6.##Monazah A, Zeinoddini M, Saeedinia AR, Xodadadi N. Detection of Coxsackievirus B3 using RT-LAMP assay: Optimization by Taguchi method and comparison of one and two step RT-LAMP. Journal of Bionanoscience 2018;12(4):515-20.##Shoushtari M, Salehi-Vaziri M, Roohvand F, Arashkia A, Jalali T, Azadmanesh K. Taguchi array optimization of the reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay for sensitive and rapid detection of dengue virus serotype 2. Biotechnol Lett 2021;43(11):2149-60.##Ganguli A, Mostafa A, Berger J, Aydin MY, Sun F, deRamirez SAS, et al. Rapid isothermal amplification and portable detection system for SARS-CoV-2. Proc Natl Acad Sci USA 2020;117(37):22727-35.##Lau YL, Ismail I, Mustapa NI, Lai MY, Soh TST, Hassan A, et al. Real-time reverse transcription loop-mediated isothermal amplification for rapid detection of SARS-CoV-2. PeerJ. 2020;8:e9278.##Kashir J, Yaqinuddin A. Loop mediated isothermal amplification (LAMP) assays as a rapid diagnostic for COVID-19. Med Hypotheses 2020;141:109786. ##Mousavi SM, Zeinoddini M, Saeeidinia AR, Xodadadi N. Specific and Rapid Detection of Zonula Occludens Toxin-producing Vibrio Cholerae Using LAMP. Biomacromol J 2020;6(2):139-46.##Lamb LE, Bartolone SN, Ward E, Chancellor MB. Rapid detection of novel coronavirus (COVID-19) by reverse transcription-loop-mediated isothermal amplification. PLoS One 2020 Jun 12;15(6):e0234682.##Yu L, Wu S, Hao X, Dong X, Mao L, Pelechano V, et al. Rapid detection of COVID-19 coronavirus using a reverse transcriptional loop-mediated isothermal amplification (RT-LAMP) diagnostic platform. Clin Chem 2020;66(7):975-7.##El-Tholoth M, Bau HH, Song J. A single and two-stage, closed-tube, molecular test for the 2019 novel coronavirus (COVID-19) at home, clinic, and points of entry. ChemRxiv 2020.##Zhang Y, Odiwuor N, Xiong J, Sun L, Nyaruaba RO, Wei H, et al. Rapid molecular detection of SARS-CoV-2 (COVID-19) virus RNA using colorimetric LAMP. MedRxiv 2020:2020.02. 26.20028373.##</REF>
        </REFRENCE>
    </REFRENCES>
</ARTICLE>

<ARTICLE>
    <TitleE>Recombinant Production of TP4-LYC1, A New Chimeric Peptide with Targeted Cytotoxicity to HeLa Cells</TitleE>
    <TitleF></TitleF>
    <TitleLang_ID>2</TitleLang_ID>
    <ABSTRACTS>

        <ABSTRACT>
            <Language_ID>2</Language_ID>
            <CONTENT>&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Background:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; Tilapia Piscidin 4 (TP4) showed potential anti-tumor effects against various cancer cells. Lycosine-1 (LYC1), is another &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&lt;span style=&quot;background-color:white&quot;&gt;Antimicrobial Peptides&lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; (AMP) from spider venom with targeted penetration to cancer cells without any adverse effects on normal cells. The aim of this study was to produce a soluble recombinant fusion peptide in order to diminish the cytotoxicity of TP4 against normal cells. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Methods:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; In order to express of TP4-LYC-1, TP4, and LYC1 in fusion to the inteins1/2 of pTWIN-1 vector, induction condition was optimized to earn soluble peptides. Auto-cleavage induction of inteins1/2 was performed based on IMPACT&lt;sup&gt;&amp;reg;&lt;/sup&gt; manual and their effect on cell viability of HeLa and HUVEC cells was surveyed by MTT assay. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Results:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; The best condition for accessing the most soluble peptide in fusion to the inteins was approximately similar for all three peptides (0.1 &lt;em&gt;mM&lt;/em&gt; of IPTG, at 22&lt;em&gt;&amp;deg;C&lt;/em&gt;). After the induction of self-cleavage of inteins, a band in 3, 3, and 6 &lt;em&gt;kDa&lt;/em&gt; was observed on tricine-SDS-PAGE. The IC50 values of TP4-LYC1 and TP4 against HeLa cells were calculated as 0.83, and 2.75 &lt;em&gt;&amp;micro;M&lt;/em&gt;, respectively. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Conclusion:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; In the present study, a novel chimeric peptide, TP4-LYC1, was successfully produced. This fusion protein can act as a safe bio-molecule with potent cytotoxic effects against cancer cells, but the penetration ability and determination of cell death mechanism must be performed in order to have more precise view on the apoptosis induction of this recombinant peptide.&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
</CONTENT>
        </ABSTRACT>
    </ABSTRACTS>
    <PAGES>
        <PAGE>
            <FPAGE>9</FPAGE>
            <TPAGE>15</TPAGE>
        </PAGE>
    </PAGES>
    <AUTHORS>
        <AUTHOR>
<Name>Hanieh</Name>
<MidName></MidName>
<Family>Mohammad Pour</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Pharmaceutical Biotechnology, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Department of Pharmaceutical Biotechnology, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Ali</Name>
<MidName></MidName>
<Family>Jahanian-Najafabadi</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Pharmaceutical Biotechnology, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Department of Pharmaceutical Biotechnology, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Fatemeh</Name>
<MidName></MidName>
<Family>Shafiee</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization></Organization>
</Organizations>
<Universities>
<University></University>
</Universities>
<Countries>
<Country></Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR>
    </AUTHORS>
    <KEYWORDS>
        <KEYWORD><KeyText>Cell survival</KeyText></KEYWORD><KEYWORD><KeyText>HeLa cells</KeyText></KEYWORD><KEYWORD><KeyText>Inteins</KeyText></KEYWORD><KEYWORD><KeyText>Spider venoms</KeyText></KEYWORD><KEYWORD><KeyText>Tilapia</KeyText></KEYWORD>
    </KEYWORDS>
    <PDFFileName>60561.pdf</PDFFileName>
    <REFRENCES>
        <REFRENCE>
            <REF>Mcphee JB, Hancock RE. Function and therapeutic potential of host defense peptides. J Pept Sci 2005;11(11):677-87. ##Zanetti M. Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol 2004;75(1):39-48.##Mader JS, Salsman J, Conrad DM, Hoskin DW. Bovine lactoferricin selectively induces apoptosis in human leukemia and carcinoma cell lines. Mol Cancer Ther 2005;4(4):612-24.##Furlong SJ, Mader JS, Hoskin DW. Lactoferricin-induced apoptosis in estrogen-nonresponsive MDA-MB-435 breast cancer cells is enhanced by C6 ceramide or tamoxifen. Oncol Rep 2006;15(5):1385-90. ##Raghuraman H, Chattopadhyay A. Cholesterol inhibits the lytic activity of melittin in erythrocytes. Chem Phys Lipids 2005;134(2):183-9.##Risso A, Zanetti M, Gennaro R. Cytotoxicity and apoptosis mediated by two peptides of innate immunity. Cell Immunol 1998;189(2):107-15.##Chavakis T, Cines DB, Rhee JS, Liang OD, Schubert U, Hammes HP, ET AL. Regulation of neovascularization by human neutrophil peptides (α-defensins): a link between inflammation and angiogenesis. FASEB J 2004;18(11):1306-8. ##Mader JS, Hoskin DW. Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment. Expert Opin Investig Drugs 2006;15(8):933-46. ##Neshani A, Eidgahi MR, Zare H, Ghazvini K. Extended-Spectrum antimicrobial activity of the Low cost produced Tilapia Piscidin 4 (TP4) marine antimicrobial peptide. J Res Med Dent Sci 2018;6(5):327-4.##Ting CH, Liu YC, Lyu PC, Chen JY. Nile tilapia derived antimicrobial peptide TP4 exerts antineoplastic activity through microtubule disruption. Mar Drugs 2018;16(12):462. ##Ting CH, Chen JY. Nile tilapia derived TP4 shows broad cytotoxicity toward to non-small-cell lung cancer cells. Mar Drugs 2018;16(12):506. ##Ting CH, Chen YC, Wu CJ, Chen JY. Targeting FOSB with a cationic antimicrobial peptide, TP4, for treatment of triple-negative breast cancer. Oncotarget 2016;7(26):40329-47. ##Su BC, Pan CY, Chen JY. Antimicrobial peptide TP4 induces ROS-mediated necrosis by triggering mitochondrial dysfunction in wild-type and mutant p53 glioblastoma cells. Cancers 2019;11(2):171. ##Kuo HM, Tseng CC, Chen NF, Tai MH, Hung HC, Feng CWet al. MSP-4, an antimicrobial peptide, induces apoptosis via activation of extrinsic Fas/FasL-and intrinsic mitochondria-mediated pathways in one osteosarcoma cell line. Mar Drugs 2018;16(1):8. ##Liu Z, Deng M, Xiang J, Ma H, Hu W, Zhao Y, et al. A novel spider peptide toxin suppresses tumor growth through dual signaling pathways. Curr Mol Med 2012;12(10):1350-60. ##Tan H, Huang Y, Xu J, Chen B, Zhang P, Ye Z, et al. Spider toxin peptide lycosin-I functionalized gold nanoparticles for in vivo tumor targeting and therapy. Theranostics 2017; 7(12):3168-78. ##Amrollahi-Nia R, Akbari V, Shafiee F. DFF40-iRGD, a novel chimeric protein with efficient cytotoxic and apoptotic effects against triple-negative breast cancer cells. Biotechnol Lett 2021;43(10):1967-76. ##Luan C, Xie YG, Pu YT, Zhang HW, Han FF, Feng J, et al. Recombinant expression of antimicrobial peptides using a novel self-cleaving aggregation tag in Escherichia coli. Can J Microbiol 2014;60(3):113-20. ##Ghobadi M, Shafiee F. Recombinant production of BIF1-iRGD fusion protein with cytotoxic and apoptotic effects against breast cancer cell lines. Biomedical Research and Therapy. In press.##Feghhi-Najafabadi S, Shafiee F. Recombinant Production of a Mutant Form of Soluble IL-6 Receptor with Inhibitory Effects against Interleukin-6. Iran J Biotechnol 2022;20(1):e3021. ##Adelnia R, Shafiee F. Recombinant production and one-step purification of IL-1Ra in Escherichia coli and evaluation of its IL-1 antagonizing efficacy. Iran J Immunol 2021;18(2):141-9. ##Shafiee F, Minaiyan G, Moazen F, Jahanian-Najafabadi A. Recombinant production and intein-mediated purification of an antimicrobial peptide, BR2. International Journal of Peptide Research and Therapeutics 2017;23(4):501-7.##</REF>
        </REFRENCE>
    </REFRENCES>
</ARTICLE>

<ARTICLE>
    <TitleE>Effect of Intra-ovarian Injection of Mesenchymal Stem Cells or its Conditioned Media on Repeated OPU-IVEP Outcomes in Jersey Heifers and Its Relationship with Follicular Fluid Inflammatory Markers</TitleE>
    <TitleF></TitleF>
    <TitleLang_ID>2</TitleLang_ID>
    <ABSTRACTS>

        <ABSTRACT>
            <Language_ID>2</Language_ID>
            <CONTENT>&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Background:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; Repeated Ovum Pick Up (OPU) could have a detrimental effect on ovarian function, reducing &lt;em&gt;In Vitro&lt;/em&gt; Embryo Production (IVEP). The present study examined the therapeutic effect of adipose&amp;ndash;derived Mesenchymal Stem Cells (MSCs) or its Conditioned Medium (ConM) on ovarian trauma following repeated OPU. Resolvin E1 (RvE1) and Interleukin-12 (IL-12) were investigated as biomarkers.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Methods:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; Jersey heifers (n=8) experienced 11 OPU sessions including 5 pre-treatment and 6 treatment sessions. Heifers received intra-ovarian administration of MSCs or ConM (right ovary) and Dulbecco&amp;rsquo;s Modified Phosphate Buffer Saline (DMPBS; left ovary) after OPU in sessions 5 and 8 and 2 weeks after session 11. The concentrations of RvE1 and IL-12 in follicular fluid was evaluated on sessions 1, 5, 6, 9, and 4 weeks after session 11. Following each OPU session, the IVEP parameters were recorded.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Results:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; Intra-ovarian administration of MSCs, ConM, and DMPBS did not affect IVEP parameters (p&amp;gt;0.05). The concentration of IL-12 in follicular fluid increased at the last session of pre-treatment (Session 5; p&amp;lt;0.05) and remained elevated throughout the treatment period. There was no correlation between IL-12 and IVEP parameters (p&amp;gt;0.05). However, RvE1 remained relatively high during the pre-treatment and decreased toward the end of treatment period (p&amp;lt;0.05). This in turn was associated with decline in some IVEP parameters (p&amp;lt;0.05).&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Conclusion:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; Intra-ovarian administration of MSCs or ConM during repeated OPU did not enhance IVEP outcomes in Bos taurus heifers. The positive association between RvE1 and some of IVEP parameters could nominate RvE1 as a promising biomarker to predict IVEP parameters following repeated OPU. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
</CONTENT>
        </ABSTRACT>
    </ABSTRACTS>
    <PAGES>
        <PAGE>
            <FPAGE>16</FPAGE>
            <TPAGE>28</TPAGE>
        </PAGE>
    </PAGES>
    <AUTHORS>
        <AUTHOR>
<Name>Ali</Name>
<MidName></MidName>
<Family>Sarvari</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Theriogenology, Faculty of Veterinary Medicine, University of TehranReproductive Biotechnology Research Center, Avicenna Research Institute, ACECR</Organization>
</Organizations>
<Universities>
<University>Department of Theriogenology, Faculty of Veterinary Medicine, University of Tehran</University>
</Universities>
<Countries>
<Country>IranIran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Amir</Name>
<MidName></MidName>
<Family>Niasari-Naslaji</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Theriogenology, Faculty of Veterinary Medicine, University of Tehran</Organization>
</Organizations>
<Universities>
<University>Department of Theriogenology, Faculty of Veterinary Medicine, University of Tehran</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Abolfazl</Name>
<MidName></MidName>
<Family>Shirazi</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization></Organization>
</Organizations>
<Universities>
<University></University>
</Universities>
<Countries>
<Country></Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Banafsheh</Name>
<MidName></MidName>
<Family>Heidari</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Photo Healing and Regeneration, Medical Laser Research Center, Yara Institute, ACECR</Organization>
</Organizations>
<Universities>
<University>Department of Photo Healing and Regeneration, Medical Laser Research Center, Yara Institute, ACECR</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Sara</Name>
<MidName></MidName>
<Family>Borjian Boroujeni</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR</Organization>
</Organizations>
<Universities>
<University></University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Mohammad Hossein</Name>
<MidName></MidName>
<Family>Moradi</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Animal Sciences, Faculty of Agriculture and Natural Resources, Arak University</Organization>
</Organizations>
<Universities>
<University>Department of Animal Sciences, Faculty of Agriculture and Natural Resources, Arak University</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Mohammad Mehdi</Name>
<MidName></MidName>
<Family>Naderi</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR</Organization>
</Organizations>
<Universities>
<University></University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Bahareh</Name>
<MidName></MidName>
<Family>Behzadi</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR</Organization>
</Organizations>
<Universities>
<University></University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Mohammad-Mahdi </Name>
<MidName></MidName>
<Family>Mehrazar</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR</Organization>
</Organizations>
<Universities>
<University>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Mohammad Mehdi</Name>
<MidName></MidName>
<Family>Dehghan</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Surgery and Radiology, Faculty of Veterinary Medicine, University of Tehran</Organization>
</Organizations>
<Universities>
<University>Department of Surgery and Radiology, Faculty of Veterinary Medicine, University of Tehran</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR>
    </AUTHORS>
    <KEYWORDS>
        <KEYWORD><KeyText>Animals</KeyText></KEYWORD><KEYWORD><KeyText>Biomarkers</KeyText></KEYWORD><KEYWORD><KeyText>Cattle</KeyText></KEYWORD><KEYWORD><KeyText>Conditioned medium</KeyText></KEYWORD><KEYWORD><KeyText>Follicular fluid</KeyText></KEYWORD><KEYWORD><KeyText>Inflammation</KeyText></KEYWORD><KEYWORD><KeyText>Interleukin-12</KeyText></KEYWORD><KEYWORD><KeyText>Ovary</KeyText></KEYWORD><KEYWORD><KeyText>Resolvin E1</KeyText></KEYWORD><KEYWORD><KeyText>Stem cells</KeyText></KEYWORD>
    </KEYWORDS>
    <PDFFileName>60562.pdf</PDFFileName>
    <REFRENCES>
        <REFRENCE>
            <REF>Nicholas F, Smith C. Increased rates of genetic change in dairy cattle by embryo transfer and splitting. Anim Sci 1983;36(3):341-53.##Pryce JE, Goddard ME, Raadsma HW, Hayes BJ. Deterministic models of breeding scheme designs that incorporate genomic selection. J Dairy Sci 2010;93(11):5455-66.##Granleese T, Clark SA, Swan AA, van der Werf JH. Increased genetic gains in sheep, beef and dairy breeding programs from using female reproductive technologies combined with optimal contribution selection and genomic breeding values. Genet Sel Evol 2015;47(1):70. ##Meuwissen TH, Hayes BJ, Goddard M. Prediction of total genetic value using genome-wide dense marker maps. Genetics 2001;157(4):1819-29. ##Leitch H, Smith C, Burnside E, Quinton M. Genetic response and inbreeding with different selection methods and mating designs for nucleus breeding programs of dairy cattle. J Dairy Sci 1994;77(6):1702-18. ##Neglia G, Gasparrini B, Vecchio D, Boccia L, Varricchio E, Di Palo R, et al. Long term effect of Ovum Pick-up in buffalo species. Anim Reprod Sci 2011;123(3-4):180-6. ##Malard PF, Peixer MA, Grazia JG, Brunel HdSS, Feres LF, Villarroel CL, et al. Intraovarian injection of mesenchymal stem cells improves oocyte yield and in vitro embryo production in a bovine model of fertility loss. Sci Rep 2020;10(1):8018.##Petyim S, B&#229;ge R, Forsberg M, Rodriguez‐Martinez H, Larsson B. Effects of repeated follicular punctures on ovarian morphology and endocrine parameters in dairy heifers. J Vet Med Series A 2001;48(8):449-63. ##Gibbons J, Beal W, Krisher R, Faber E, Pearson R, Gwazdauskas F. Effects of once-versus twice-weekly transvaginal follicular aspiration on bovine oocyte recovery and embryo development. Theriogenology 1994;42(3):405-19. ##Viana JH, Palhao MP, Siqueira LG, Fonseca JF, Camargo LS. Ovarian follicular dynamics, follicle deviation, and oocyte yield in Gyr breed (Bos indicus) cows undergoing repeated ovum pick-up. Theriogenology 2010;73(7):966-72. ##Viana JHM, Pereira NES, Faria OAC, Dias LRO, Oliveira ER, Fernandes CAC, et al. Active immunization against GnRH as an alternative therapeutic approach for the management of Bos indicus oocyte donors diagnosed with chronic cystic ovarian disease. Theriogenology 2021;172:133-41.##Gilchrist R, Ritter L, Armstrong D. Oocyte–somatic cell interactions during follicle development in mammals. Anim Reprod Sci 2004;82:431-46. ##Leroy J, Rizos D, Sturmey R, Bossaert P, Gutierrez-Adan A, Van Hoeck V, et al. Intrafollicular conditions as a major link between maternal metabolism and oocyte quality: a focus on dairy cow fertility. Reprod Fertil Dev 2011;24(1):1-12. ##Leroy J, Vanholder T, Delanghe J, Opsomer G, Van Soom A, Bols P, et al. Metabolic changes in follicular fluid of the dominant follicle in high-yielding dairy cows early post-partum. Theriogenology 2004;62(6):1131-43. ##Leroy J, Vanholder T, Mateusen B, Christophe A, Opsomer G, de Kruif A, et al. Non-esterified fatty acids in follicular fluid of dairy cows and their effect on developmental capacity of bovine oocytes in vitro. Reproduction 2005;130(4):485-95. ##Robker RL, Akison LK, Bennett BD, Thrupp PN, Chura LR, Russell DL, et al. Obese women exhibit differences in ovarian metabolites, hormones, and gene expression compared with moderate-weight women.  J Clin Endocrinol Metab 2009;94(5):1533-40. ##Robker RL. Evidence that obesity alters the quality of oocytes and embryos. Pathophysiology 2008;15(2):115-21. ##Pantasri T, Norman RJ. The effects of being overweight and obese on female reproduction: a review. Gynecol Endocrinol 2014;30(2):90-4. ##Brewer CJ, Balen AH. Focus on obesity. The adverse effects of obesity on conception and implantation. Reproduction 2010;140(3):347-64. ##Van Hoeck V, Sturmey RG, Bermejo-Alvarez P, Rizos D, Gutierrez-Adan A, Leese HJ, et al. Elevated non-esterified fatty acid concentrations during bovine oocyte maturation compromise early embryo physiology. PloS One 2011;6(8):e23183. ##Mack M. Inflammation and fibrosis. Matrix Biol 2018;68:106-21. ##Chastant S, Saint-Dizier M. Inflammation: friend or foe of bovine reproduction? Anim Reprod 2019;16(3):539-47. ##Sheldon IM, Cronin JG, Pospiech M, Turner ML. Symposium review: Mechanisms linking metabolic stress with innate immunity in the endometrium. J Dairy Sci 2018;101(4):3655-64. ##Herath S, Williams EJ, Lilly ST, Gilbert RO, Dobson H, Bryant CE, et al. Ovarian follicular cells have innate immune capabilities that modulate their endocrine function. Reproduction 2007;134(5):683-93. ##Fu X, He Y, Xie C, Liu W. Bone marrow mesenchymal stem cell transplantation improves ovarian function and structure in rats with chemotherapy-induced ovarian damage. Cytotherapy 2008;10(4):353-63.##He Y, Chen D, Yang L, Hou Q, Ma H, Xu X. The therapeutic potential of bone marrow mesenchymal stem cells in premature ovarian failure. Stem Cell Res Ther 2018;9(1):263. ##Pontes JH, Silva KC, Basso AC, Rigo AG, Ferreira CR, Santos GM, et al. Large-scale in vitro embryo production and pregnancy rates from Bos taurus, Bos indicus, and indicus-taurus dairy cows using sexed sperm. Theriogenology 2010;74(8):1349-55. ##Pouryousefi-Koodehi T, Shayegan S, Hashemi S, Arefnezhad R, Roghani-Shahraki H, Motedayyen H, et al. Can mesenchymal stem cells derived from adipose tissue and their conditioned medium improve ovarian functions? A mini-review. Zygote 2022;30(5):589-92. ##Elfayomy AK, Almasry SM, El-Tarhouny SA, Eldomiaty MA. Human umbilical cord blood-mesenchymal stem cells transplantation renovates the ovarian surface epithelium in a rat model of premature ovarian failure: Possible direct and indirect effects. Tissue Cell 2016;48(4):370-82.##Zhao YX, Chen SR, Su PP, Huang FH, Shi YC, Shi QY, et al. Using mesenchymal stem cells to treat female infertility: An update on female reproductive diseases. Stem Cells Int 2019;2019:9071720. ##English K. Mechanisms of mesenchymal stromal cell immunomodulation. Immunol Cell Biol 2013;91(1):19-26. ##Shi Y, Su J, Roberts AI, Shou P, Rabson AB, Ren G. How mesenchymal stem cells interact with tissue immune responses. Trends Immunol 2012;33(3):136-43. ##Zachar L, Bačenkov&#225; D, Rosocha J. Activation, homing, and role of the mesenchymal stem cells in the inflammatory environment. J Inflamm Res 2016:231-40. ##Nagyova M, Slovinska L, Blasko J, Grulova I, Kuricova M, Cigankova V, et al. A comparative study of PKH67, DiI, and BrdU labeling techniques for tracing rat mesenchymal stem cells. In Vitro Cell Dev Biol Animal 2014;50(7):656-63. ##Gao Y, Zhu Z, Zhao Y, Hua J, Ma Y, Guan W. Multilineage potential research of bovine amniotic fluid mesenchymal stem cells. Int J Mol Sci 2014;15(3):3698-710. ##Ma S, Xie N, Li W, Yuan B, Shi Y, Wang Y. Immunobiology of mesenchymal stem cells. Cell Death Differ 2014;21(2):216-25. ##Wu Y, Chen L, Scott PG, Tredget EE. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 2007;25(10):2648-59. ##Sheikhansari G, Aghebati-Maleki L, Nouri M, Jadidi-Niaragh F, Yousefi M. Current approaches for the treatment of premature ovarian failure with stem cell therapy. Biomed Pharmacother 2018;102:254-62. ##Li Z, Zhang M, Tian Y, Li Q, Huang X. Mesenchymal stem cells in premature ovarian insufficiency: mechanisms and prospects. Front Cell Dev Biol 2021;9:718192. ##Cui L, Bao H, Liu Z, Man X, Liu H, Hou Y, et al. hUMSCs regulate the differentiation of ovarian stromal cells via TGF-β1/Smad3 signaling pathway to inhibit ovarian fibrosis to repair ovarian function in POI rats. Stem Cell Res Ther 2020;11(1):386. ##Meirelles Lda S, Fontes AM, Covas DT, Caplan AI. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev 2009;20(5-6):419-27.##Hill ABT, Bressan FF, Murphy BD, Garcia JM. Applications of mesenchymal stem cell technology in bovine species. Stem Cell Res Ther 2019;10(1):44. ##Yoon SY. Mesenchymal stem cells for restoration of ovarian function. Clin Exp Reprod Med 2019;46(1):1-7. ##Fazeli Z, Abedindo A, Omrani MD, Ghaderian SMH. Mesenchymal stem cells (MSCs) therapy for recovery of fertility: a systematic review. Stem Cell Rev Rep 2018;14(1):1-12. ##Takafuji Y, Hori M, Mizuno T, Harada-Shiba M. Humoral factors secreted from adipose tissue-derived mesenchymal stem cells ameliorate atherosclerosis in Ldlr−/− mice. Cardiovasc Res 2019;115(6):1041-51. ##Zheng J, Wang Q, Leng W, Sun X, Peng J. Bone marrow‑derived mesenchymal stem cell‑conditioned medium attenuates tubulointerstitial fibrosis by inhibiting monocyte mobilization in an irreversible model of unilateral ureteral obstruction. Mol Med Rep 2018;17(6):7701-7. ##Gunawardena TNA, Rahman MT, Abdullah BJJ, Abu Kasim NH. Conditioned media derived from mesenchymal stem cell cultures: The next generation for regenerative medicine. J Tissue Eng Regen Med 2019;13(4):569-86. ##Zachar L, Bačenkov&#225; D, Soltys J, Rosocha J. Bioactive mediators associated with mesenchymal stem cells-mediated immunomodulation. J Bone Stem Res 2015;1(2):006.##Soares JG, Rossi GF, Bayeux BM, Rochetti RC, Moraes GF, Elliff FM, et al. Stem cells injection in the ovary increased the oocyte and embryo production in bovine females. Fertil  Steril 2018;110(4):e431-e2.##Ribeiro ES, Gomes G, Greco LF, Cerri RLA, Vieira-Neto A, Monteiro PLJ, Jr., et al. Carryover effect of postpartum inflammatory diseases on developmental biology and fertility in lactating dairy cows. J Dairy Sci 2016;99(3):2201-20.##Sarapik A, Velthut A, Haller-Kikkatalo K, Faure GC, Bene MC, de Carvalho Bittencourt M, et al. Follicular proinflammatory cytokines and chemokines as markers of IVF success. Clin Dev Immunol 2012;2012:606459. ##Bedaiwy M, Shahin AY, AbulHassan AM, Goldberg JM, Sharma RK, Agarwal A, et al. Differential expression of follicular fluid cytokines: relationship to subsequent pregnancy in IVF cycles. Reprod Biomed online 2007;15(3):321-5. ##Ledee N, Lombroso R, Lombardelli L, Selva J, Dubanchet S, Chaouat G, et al. Cytokines and chemokines in follicular fluids and potential of the corresponding embryo: the role of granulocyte colony-stimulating factor. Hum Reprod 2008;23(9):2001-9. ##Gazvani MR, Bates M, Vince G, Christmas S, Lewis-Jones DI, Kingsland C. Follicular fluid concentrations of interleukin-12 and interleukin-8 in IVF cycles. Fertil Steri 2000;74(5):953-8. ##Arita M, Bianchini F, Aliberti J, Sher A, Chiang N, Hong S, et al. Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J Exp Med 2005;201(5):713-22. ##Arita M, Oh SF, Chonan T, Hong S, Elangovan S, Sun Y-P, et al. Metabolic inactivation of resolvin E1 and stabilization of its anti-inflammatory actions. J Biol Chem 2006;281(32):22847-54. ##Zhang Y, Zhu Z, Li H, Zhu M, Peng X, Xin A, et al. Resolvin E1 in follicular fluid acts as a potential biomarker and improves oocyte developmental competence by optimizing cumulus cells. Front Endocrinol (Lausanne) 2020;11:210. ##Lopes A, Martinussen T, Greve T, Callesen H. Effect of days post‐partum, breed and ovum pick‐up scheme on bovine oocyte recovery and embryo development. Reprod Domest Anim 2006;41(3):196-203.##Hasler JF. The current status of oocyte recovery, in vitro embryo production, and embryo transfer in domestic animals, with an emphasis on the bovine. J Anim Sci 1998;76(suppl_3):52-74.##Kruip TA, Boni R, Wurth Y, Roelofsen M, Pieterse M. Potential use of ovum pick-up for embryo production and breeding in cattle. Theriogenology 1994;42(4):675-84. ##Stubbings R, Walton J. Effect of ultrasonically-guided follicle aspiration on estrous cycle and follicular dynamics in Holstein cows. Theriogenology 1995;43(4):705-12. ##Fry R. Factors affecting transvaginal oocyte pick up in heifers. Theriogenology 1994;41:197 (abst).##Naji A, Rouas-Freiss N, Durrbach A, Carosella ED, Sens&#233;b&#233; L, Deschaseaux F. Concise review: Combining human leukocyte antigen G and mesenchymal stem cells for immunosuppressant biotherapy. Stem Cells 2013;31(11):2296-303. ##Wang J, Liu C, Fujino M, Tong G, Zhang Q, Li X-K, et al. Stem cells as a resource for treatment of infertility-related diseases. Curr Mol Med 2019;19(8):539-46. ##Bukowska J, Szostek-Mioduchowska AZ, Kopcewicz M, Walendzik K, Machcinska S, Gawronska-Kozak B. Adipose-derived stromal/stem cells from large animal models: from basic to applied science. Stem Cell Rev Rep 2021;17(3):719-38. ##Takehara Y, Yabuuchi A, Ezoe K, Kuroda T, Yamadera R, Sano C, et al. The restorative effects of adipose-derived mesenchymal stem cells on damaged ovarian function. Lab Invest 2013;93(2):181-93. ##Su J, Ding L, Cheng J, Yang J, Li Xa, Yan G, et al. Transplantation of adipose-derived stem cells combined with collagen scaffolds restores ovarian function in a rat model of premature ovarian insufficiency. Hum. Reprod 2016;31(5):1075-86. ##Krampera M. Mesenchymal stromal cell ‘licensing’: a multistep process. Leukemia 2011;25(9):1408-14.##DelaRosa O, Dalemans W, Lombardo E. Toll-like receptors as modulators of mesenchymal stem cells. Front Immunol 2012;3:182. ##Aerts J, Bols P. Ovarian follicular dynamics: a review with emphasis on the bovine species. Part I: Folliculogenesis and pre‐antral follicle development. Reprod Domest Anim 2010;45(1):171-9. ##Binato R, de Souza Fernandez T, Lazzarotto‐Silva C, Du Rocher B, Mencalha A, Pizzatti L, et al. Stability of human mesenchymal stem cells during in vitro culture: considerations for cell therapy. Cell Prolif 2013;46(1):10-22. ##Madeira A, da Silva CL, dos Santos F, Camafeita E, Cabral JM, Sa-Correia I. Human mesenchymal stem cell expression program upon extended ex-vivo cultivation, as revealed by 2-DE-based quantitative proteomics. PLoS One 2012;7(8):e43523. ##Jansen BJ, Gilissen C, Roelofs H, Schaap-Oziemlak A, Veltman JA, Raymakers RA, et al. Functional differences between mesenchymal stem cell populations are reflected by their transcriptome. Stem Cells Dev 2010;19(4):481-90. ##Peroni JF, Borjesson DL. Anti-inflammatory and immunomodulatory activities of stem cells. Vet Clin North Am Equine Pract 2011;27(2):351-62. ##DelaRosa O, Lombardo E, Beraza A, Mancheno-Corvo P, Ramirez C, Menta R, et al. Requirement of IFN-γ–mediated indoleamine 2, 3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose–derived stem cells. Tissue Eng Part A 2009;15(10):2795-806.##Deuse T, Stubbendorff M, Tang-Quan K, Phillips N, Kay MA, Eiermann T, et al. Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells. Cell Transplant 2011;20(5):655-67. ##Prasanna SJ, Gopalakrishnan D, Shankar SR, Vasandan AB. Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially. PLoS One 2010;5(2):e9016. ##Watanabe YF, de Souza AH, Mingoti RD, Ferreira RM, Batista EOS, Dayan A, et al. Number of oocytes retrieved per donor during OPU and its relationship with in vitro embryo production and field fertility following embryo transfer. Anim Reprod 2018;14(3):635-44.##Kemp K, Gray E, Mallam E, Scolding N, Wilkins A. Inflammatory cytokine induced regulation of superoxide dismutase 3 expression by human mesenchymal stem cells. Stem Cell Rev Rep 2010;6(4):548-59. ##Ren G, Zhang L, Zhao X, Xu G, Zhang Y, Roberts AI, et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem cell 2008;2(2):141-50. ##Hemeda H, Jakob M, Ludwig A-K, Giebel B, Lang S, Brandau S. Interferon-γ and tumor necrosis factor-α differentially affect cytokine expression and migration properties of mesenchymal stem cells. Stem Cells Dev 2010;19(5):693-706. ##Opitz CA, Litzenburger UM, Lutz C, Lanz TV, Tritschler I, K&#246;ppel A, et al. Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2, 3-dioxygenase-1 via interferon-β and protein kinase R. Stem Cells 2009;27(4):909-19. ##Kay AG, Long G, Tyler G, Stefan A, Broadfoot SJ, Piccinini AM, et al. Mesenchymal stem cell-conditioned medium reduces disease severity and immune responses in inflammatory arthritis. Sci  Rep 2017;7(1):18019. ##Safari S, Eidi A, Mehrabani M, Fatemi MJ, Sharifi AM. Conditioned Medium of Adipose-Derived Mesenchymal Stem Cells as a Promising Candidate to Protect High Glucose-Induced Injury in Cultured C28I2 Chondrocytes. Adv Pharm Bull 2022;12(3):632-40. ##Lee SH. Human Adipose-Derived Stem Cells’ Paracrine Factors in Conditioned Medium Can Enhance Porcine Oocyte Maturation and Subsequent Embryo Development. Int J Mol Sci 2021;22(2):579.##Blazquez R, Sanchez-Margallo FM, de la Rosa O, Dalemans W, &#193;lvarez V, Tarazona R, et al. Immunomodulatory potential of human adipose mesenchymal stem cells derived exosomes on in vitro stimulated T cells. Front Immunol 2014;5:556. ##Crisostomo PR, Wang Y, Markel TA, Wang M, Lahm T, Meldrum DR. Human mesenchymal stem cells stimulated by TNF-α, LPS, or hypoxia produce growth factors by an NFκB-but not JNK-dependent mechanism. Am J Physiol Cell Physiol 2008;294(3):C675-C82. ##Jin Q-H, Kim H-K, Na J-Y, Jin C, Seon J-K. Anti-inflammatory effects of mesenchymal stem cell-conditioned media inhibited macrophages activation in vitro. Sci Rep 2022;12(1):4754. ##Langrish CL, McKenzie BS, Wilson NJ, de Waal Malefyt R, Kastelein RA, Cua DJ. IL‐12 and IL‐23: master regulators of innate and adaptive immunity. Immunol Rev 2004;202(1):96-105. ##Ostanin A, Aizikovich B, Aizikovich I, Kozhin AY, Chernykh E. Role of cytokines in the regulation of reproductive function. Bull Exp Biol Med 2007;143(1):75-9. ##Singh AK, Dutta M, Chattopadhyay R, Chakravarty B, Chaudhury K. Intrafollicular interleukin-8, interleukin-12, and adrenomedullin are the promising prognostic markers of oocyte and embryo quality in women with endometriosis. J Assist Reprod Genet 2016;33(10):1363-72. ##</REF>
        </REFRENCE>
    </REFRENCES>
</ARTICLE>

<ARTICLE>
    <TitleE>Orexin-1 Receptor Antagonist SB-334867 Enhances Formalin-Induced Nociceptive Behaviors in Adult Male Rats</TitleE>
    <TitleF></TitleF>
    <TitleLang_ID>2</TitleLang_ID>
    <ABSTRACTS>

        <ABSTRACT>
            <Language_ID>2</Language_ID>
            <CONTENT>&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:16pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Background:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; Orexin (hypocretin) is one of the hypothalamic neuropeptides that plays a critical role in some behaviors including feeding, sleep, arousal, reward processing, and drug addiction. Neurons that produce orexin are scattered mediolaterally within the Dorsomedial Hypothalamus (DMH) and the lateral hypothalamus. In the current research, we assessed the impact of prolonged application of the antagonist of Orexin Receptor 1 (&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;OXR1) on nociceptive behaviors in adult male rats. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:16pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Methods:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; Sixteen Wistar rats received subcutaneous (s.c.) injections of the OXR1 antagonist, SB-334867 (20 &lt;em&gt;mg/kg&lt;/em&gt;, &lt;em&gt;i.p&lt;/em&gt;.), or its vehicle repetitively from Postnatal Day 1 (PND1)-PND30. On the 30&lt;sup&gt;th&lt;/sup&gt; day following the final application of the &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;OXR1&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; antagonist formalin-provoked pain was evaluated by injecting formalin. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:16pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Results:&lt;/span&gt;&lt;/strong&gt; &lt;span style=&quot;font-size:10.0pt&quot;&gt;Administration of the OXR1 antagonist in the long-term augmented the formalin-provoked nociceptive behaviors in interphase and phase II of the formalin-induced pain. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:16pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Conclusion:&lt;/span&gt;&lt;/strong&gt; &lt;span style=&quot;font-size:10.0pt&quot;&gt;Current results showed that the continued inhibiting OXR1 might be implicated in formalin-induced nociceptive behaviors. Therefore, the present study highlighted the effect of orexin on analgesia.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
</CONTENT>
        </ABSTRACT>
    </ABSTRACTS>
    <PAGES>
        <PAGE>
            <FPAGE>29</FPAGE>
            <TPAGE>33</TPAGE>
        </PAGE>
    </PAGES>
    <AUTHORS>
        <AUTHOR>
<Name>Masoumeh</Name>
<MidName></MidName>
<Family>Kourosh-Arami</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization></Organization>
</Organizations>
<Universities>
<University></University>
</Universities>
<Countries>
<Country></Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Alireza</Name>
<MidName></MidName>
<Family>Komaki</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Neuroscience, School of Science and Advanced Technologies in Medicine, Hamadan University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Department of Neuroscience, School of Science and Advanced Technologies in Medicine, Hamadan University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Masoumeh</Name>
<MidName></MidName>
<Family>Gholami</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Physiology, Medical College, Arak University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Department of Physiology, Medical College, Arak University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR>
    </AUTHORS>
    <KEYWORDS>
        <KEYWORD><KeyText>Formalin</KeyText></KEYWORD><KEYWORD><KeyText>Nociception</KeyText></KEYWORD><KEYWORD><KeyText>Orexin receptor 1</KeyText></KEYWORD><KEYWORD><KeyText>Orexin</KeyText></KEYWORD><KEYWORD><KeyText>SB-334867</KeyText></KEYWORD>
    </KEYWORDS>
    <PDFFileName>60563.pdf</PDFFileName>
    <REFRENCES>
        <REFRENCE>
            <REF>De Lecea L, Kilduff T, Peyron C, Gao X-B, Foye P, Danielson P, et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 1998;95(1):322-7. ##Sakurai T. The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat Rev Neurosci 2007;8(3):171-81.##Boutrel B, Cannella N, de Lecea L. The role of hypocretin in driving arousal and goal-oriented behaviors. Brain Res 2010;1314:103-11.##Khoo SY-S, Brown RM. Orexin/hypocretin based pharmacotherapies for the treatment of addiction: DORA or SORA? CNS Drugs 2014;28(8):713-30. ##Mahler SV, Smith RJ, Moorman DE, Sartor GC, Aston-Jones G. Multiple roles for orexin/hypocretin in addiction.  Prog Brain Res 2012;198:79-121. ##Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998;92(4):573-85. ##Peyron C, Tighe DK, Van Den Pol AN, De Lecea L, Heller HC, Sutcliffe JG, et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 1998;18(23):9996-10015. ##Razavi BM, Hosseinzadeh H. A review of the role of orexin system in pain modulation. Biomed Pharmacother 2017;90:187-93. ##Babaie F, Kourosh-Arami M, Farhadi M. Administration of orexin-A into the rat thalamic paraventricular nucleus enhances the naloxone induced morphine withdrawal. Drug Res (Stuttg) 2022;72(04):209-14. ##Erami E, Azhdari-Zarmehri H, Rahmani A, Ghasemi-Dashkhasan E, Semnanian S, Haghparast A. Blockade of orexin receptor 1 attenuates the development of morphine tolerance and physical dependence in rats. Pharmacol Biochem Behav 2012;103(2):212-9.##Kourosh-Arami M, Gholami M, Alavi-Kakhki SS, Komaki A. Neural correlates and potential targets for the contribution of orexin to addiction in cortical and subcortical areas. Neuropeptides 2022;95:102259. ##Majidinezhad M, Amirteymouri H, Karimi-Haghighi S, Kourosh-Arami M, Haghparast A. Orexin system in the ventral tegmental area is implicated in the rewarding properties of methamphetamine. Eur J Pharmacol 2022;930:175170. ##Samani F, Arami MK. Repeated administration of orexin into the thalamic paraventricular nucleus inhibits the development of morphine-induced analgesia. Protein Pept Lett 2022;29(1):57-63. ##Kourosh-Arami M, Javan M, Semnanian S. Inhibition of orexin receptor 1 contributes to the development of morphine dependence via attenuation of cAMP response element-binding protein and phospholipase Cβ3. J Chem Neuroanat 2020;108:101801. ##Kourosh-Arami M, Hajizadeh S. Maturation of NMDA receptor-mediated spontaneous postsynaptic currents in the rat locus coeruleus neurons. Physiol Int 2020 Apr 23;107(1):18-29. ##Babasafari M, Kourosharami M, Behman J, Farhadi M, Komaki A. Alteration of phospholipase C expression in rat visual cortical neurons by chronic blockade of orexin receptor 1. International Journal of Peptide Research and Therapeutics 2020;26(3):1485-91.##Kourosh-Arami M, Kaeidi A, Semnanian S. Extracellular calcium contributes to orexin-induced postsynaptic excitation of the rat locus coeruleus neurons. International Journal of Peptide Research and Therapeutics 2022;28(2):1-8.##Stoyanova II, Rutten WL, le Feber J. Orexin-A and orexin-B during the postnatal development of the rat brain. Cell Mol Neurobiol 2010;30(1):81-9. ##Van Den Pol AN, Patrylo PR, Ghosh PK, Gao XB. Lateral hypothalamus: early developmental expression and response to hypocr https://pubmed.ncbi.nlm.nih.gov/11298360/etin (orexin). J Comp Neurol 2001;433(3):349-63.##Shibata S, Oomura Y, Kita H. Ontogenesis of glucose sensitivity in the rat lateral hypothalamus: a brain slice study. Brain Res 1982;5(1):114-7. ##Fisher RS, Almli CR. Postnatal development of sensory influences on lateral hypothalamic neurons of the rat. Brain Res 1984;314(1):55-75.##Yamamoto T, Nozaki‐Taguchi N, Chiba T. Analgesic effect of intrathecally administered orexin‐A in the rat formalin test and in the rat hot plate test. Br J Pharmacol 2002;137(2):170-6.##Rezaei Z, Kourosh-Arami M, Azizi H, Semnanian S. Orexin type-1 receptor inhibition in the rat lateral paragigantocellularis nucleus attenuates development of morphine dependence. Neurosci Lett 2020:134875. ##Mobarakeh JI, Takahashi K, Sakurada S, Nishino S, Watanabe H, Kato M, et al. Enhanced antinociception by intracerebroventricularly administered orexin A in histamine H1 or H2 receptor gene knockout mice. Pain 2005;118(1-2):254-62.##Zarmehri HA, Semnanian S, Fathollahi Y, Erami E, Khakpay R, Azizi H, et al. Intra-periaqueductal gray matter microinjection of orexin-A decreases formalin-induced nociceptive behaviors in adult male rats. J Pain 2011;12(2):280-7. ##Heidary N, Sahraei H, Afarinesh MR, Bahari Z, Meftahi GH. Investigating the inhibition of NMDA glutamate receptors in the basolateral nucleus of the amygdala on the pain and inflammation induced by formalin in male Wistar rats. Frontiers in Biology. 2018;13(2):149-55.##Sofiabad M, Heidari N, Ghasemi E, Esmaeili MH, Haghdoost-Yazdi H, Erami E. Assesment of orexin receptor 1 in stress attenuated nociceptive behaviours in formalin test. Physiol Pharmacol 2011;15(3):395-402.##Kang X, Tang H, Liu Y, Yuan Y, Wang M. Research progress on the mechanism of orexin in pain regulation in different brain regions. Open Life Sci 2021;16(1):46-52. ##Komaki A, Shahidi S, Sarihi A, Hasanein P, Lashgari R, Haghparast A, et al. Effects of neonatal C-fiber depletion on interaction between neocortical short-term and long-term plasticity. Basic Clin Neurosci 2013;4(2):136-45. ##Kourosh-Arami M, Hosseini N, Komaki A. Brain is modulated by neuronal plasticity during postnatal development. J Physiol Sci 2021;71(1):34.##Kourosh-Arami M, Komaki A, Gholami M. Addiction-induced plasticity in underlying neural circuits. Neurol Sci 2022;43(3):1605-15.##Martindale J, Bland-Ward P, Chessell I. Inhibition of C-fibre mediated sensory transmission in the rat following intraplantar formalin. Neurosci Lett 2001;316(1):33-6. ##Kourosh-Arami M, Komaki A. Reciprocal interaction of pain and Brain: plasticity-induced pain, pain-induced plasticity, and therapeutic targets. CNS Neurol Disord Drug Targets 2023. ##Arami MK,  Mirnajafi zade J,  Komaki A, Amiri M,  Mehrpooya S, Jahanshahi A, et al. Nitric oxide in the nucleus raphe magnus modulates cutaneous blood flow in rats during hypothermia. Iran J Basic Med Sci 2015;18(10):989-92. ##Malakouti SM, Kourosh AM, Sarihi A, Hajizadeh S, Behzadi G, Shahidi S, et al. Reversible inactivation and excitation of nucleus raphe magnus can modulate tail blood flow of male wistar rats in response to hypothermia. Iranian Biomedical Journal 2008;12(4):237-40.##Mason P, Gao K, editors. Raphe magnus serotonergic neurons tonically modulate nociceptive transmission. Pain Forum; 1998: Elsevier.##Masoomeh Kourosh A, Abdolrahman S, Seyyed Mansour M, Gila B, Mehrangiz V, Iraj A. The effect of nucleus tractus solitarius nitric oxidergic neurons on blood pressure in diabetic rats. Iranian Biomedical Journal 2006;10(1):15-19.##Okada S, Katagiri A, Saito H, Lee J, Ohara K, Iinuma T, et al. Functional involvement of nucleus tractus solitarii neurons projecting to the parabrachial nucleus in trigeminal neuropathic pain. J Oral Sci 2019;61(2):370-8. ##Date Y, Mondal MS, Matsukura S, Nakazato M. Distribution of orexin-A and orexin-B (hypocretins) in the rat spinal cord. Neurosci Lett 2000;288(2):87-90. ##Bingham S, Davey P, Babbs A, Irving E, Sammons M, Wyles M, et al. Orexin-A, an hypothalamic peptide with analgesic properties. Pain 2001;92(1-2):81-90. ##</REF>
        </REFRENCE>
    </REFRENCES>
</ARTICLE>

<ARTICLE>
    <TitleE>Annexin-A5 Overexpression Increases Sensitivity of MCF-7 and MCF-7/ADR Cells to Epirubicin</TitleE>
    <TitleF></TitleF>
    <TitleLang_ID>2</TitleLang_ID>
    <ABSTRACTS>

        <ABSTRACT>
            <Language_ID>2</Language_ID>
            <CONTENT>&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Background:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; Multi-drug resistance is an important challenge in the chemotherapy of cancer. The role of annexin A5 (ANXA5) in the biology of cancer has been the focus of many studies. Breast Cancer (BC) is frequent cancer in women with high morbidity and mortality rate. The present study aimed to investigate the effects of ANXA5 overexpression on the anti-tumor activity of Epirubicin (EPI) in MCF-7 and MCF-7/ADR cells.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Methods:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; MCF-7 and MCF-7/ADR cells &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;were transfected with the &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;pAdenoVator-CMV-ANXA5-IRES-GFP&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; plasmid or mock plasmid. The overexpression of ANXA5 was evaluated using qPCR. The effects of ANXA5 overexpression and EPI on the cell viability of &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;MCF-7 and MCF-7/ADR cells &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;were measured using an MTT assay. Cell apoptosis was measured by annexin V/7-AAD flow cytometry assay. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Results:&lt;/span&gt;&lt;/strong&gt; &lt;span style=&quot;font-size:10.0pt&quot;&gt;Following the overexpression of ANXA5, the viability of MCF-7 and MCF-7/ADR was significantly decreased. Furthermore, the overexpression of ANXA5 in MCF-7 cells increased the cytotoxic effects of EPI in all doses and reduced the IC50 of EPI from 17.69 &lt;em&gt;&amp;micro;M&lt;/em&gt; to 4.07 &lt;em&gt;&amp;micro;M&lt;/em&gt;. Similarly, the overexpression of ANXA5 in MCF7-ADR cells reduced the IC50 of EPI from 27.3 &lt;em&gt;&amp;micro;M&lt;/em&gt; to 6.69 &lt;em&gt;&amp;micro;M&lt;/em&gt;. ANXA5 overexpression alone or combined with EPI treatment increased the apoptosis of MCF7 and MCF7-ADR cells.&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Conclusion:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; The results of the present study demonstrate that ANXA5 overexpression increases the sensitivity of MCF-7 and MCF-7/ADR to EPI, suggesting a possible beneficial role of ANXA5 in the therapy of BC. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
</CONTENT>
        </ABSTRACT>
    </ABSTRACTS>
    <PAGES>
        <PAGE>
            <FPAGE>34</FPAGE>
            <TPAGE>39</TPAGE>
        </PAGE>
    </PAGES>
    <AUTHORS>
        <AUTHOR>
<Name>Mahshad</Name>
<MidName></MidName>
<Family>Ghasemi</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Division of Medical Biotechnology, Department of Laboratory Sciences, School of Paramedical Sciences, Shiraz University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Division of Medical Biotechnology, Department of Laboratory Sciences, School of Paramedical Sciences, Shiraz University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Niloofar</Name>
<MidName></MidName>
<Family>Reiazi </Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Division of Medical Biotechnology, Department of Laboratory Sciences, School of Paramedical Sciences, Shiraz University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Division of Medical Biotechnology, Department of Laboratory Sciences, School of Paramedical Sciences, Shiraz University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Abbas</Name>
<MidName></MidName>
<Family>Behzad-Behbahani</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Diagnostic Laboratory Sciences and Technology Research Center, School of Paramedical Sciences, Shiraz University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Diagnostic Laboratory Sciences and Technology Research Center, School of Paramedical Sciences, Shiraz University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Mohammad Ali</Name>
<MidName></MidName>
<Family>Takhshid</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Diagnostic Laboratory Sciences and Technology Research Center, School of Paramedical Sciences, Shiraz University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Diagnostic Laboratory Sciences and Technology Research Center, School of Paramedical Sciences, Shiraz University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR>
    </AUTHORS>
    <KEYWORDS>
        <KEYWORD><KeyText>Annexin-A5</KeyText></KEYWORD><KEYWORD><KeyText>Antineoplastic agents</KeyText></KEYWORD><KEYWORD><KeyText>Breast neoplasms</KeyText></KEYWORD><KEYWORD><KeyText>Drug resistance</KeyText></KEYWORD><KEYWORD><KeyText>MCF7 cells</KeyText></KEYWORD>
    </KEYWORDS>
    <PDFFileName>60564.pdf</PDFFileName>
    <REFRENCES>
        <REFRENCE>
            <REF>Kashyap D, Pal D, Sharma R, Garg VK, Goel N, Koundal D, et al. Global increase in breast cancer incidence: risk factors and preventive measures. BioMed Res Int 2022;2022:9605439. ##Waks AG, Winer EP. Breast cancer treatment: A review. JAMA 2019;321(3):288-300.##Modi A, Roy D, Sharma S, Vishnoi JR, Pareek P, Elhence P, et al. ABC transporters in breast cancer: their roles in multidrug resistance and beyond. J Drug Target 2022;30(9):927-47. ##Amawi H, Sim HM, Tiwari AK, Ambudkar SV, Shukla S. ABC transporter-mediated multidrug-resistant cancer. Adv Exp Med Biol 2019;1141:549-80.##Zhang H, Zhang Z, Guo T, Chen G, Liu G, Song Q, et al. Annexin A protein family: Focusing on the occurrence, progression and treatment of cancer. Front Cell Dev Biol 2023;11:1141331. ##de Souza Ferreira LP, da Silva RA, Gil CD, Geisow MJ. Annexin A1, A2, A5, and A6 involvement in human pathologies. Proteins 2023;91(9):1191-204. ##Wang J, Liu J, Cao Y, Hu M, Hua Z. Domain IV of Annexin A5 is critical for binding calcium and guarantees its maximum binding to the phosphatidylserine membrane. Molecules 2017;22(12):2256.##Lee SE, Lee CM, Won JE, Jang G-Y, Lee JH, Park SH, et al. Enhancement of anticancer immunity by immunomodulation of apoptotic tumor cells using annexin A5 protein-labeled nanocarrier system. Biomaterials 2022;288:121677. ##Woodward A, Faria GNF, Harrison RG. Annexin A5 as a targeting agent for cancer treatment. Cancer Lett 2022;547:215857. ##Li X, Ma W, Wang X, Ci Y, Zhao Y. Annexin A5 overexpression might suppress proliferation and metastasis of human uterine cervical carcinoma cells. Cancer Biomark 2018;23(1):23-32. ##Wang X, Dai Y, Zhang J, Li X. Annexin A5 suppression promotes the progression of cervical cancer. Arch Gynecol Obstet 2023;307(3):937-43.##Zamani B, Ramazani A, Saberzadeh J, Rostampour P, Takhshid MA. The effect of Annexin A5 overexpression on invasiveness and expression of the genes involved in epithelial-mesenchymal transition of HCT 116 cell line. Mol Biol Res Commun 2023;12(2):77-85. ##Zhang X, Zhou H, Han W, Zhang D, Han X, Hou L, et al. ANXA5 promotes glioma progression through the FAk/PI3K/AKT pathway. 2022.##Khasraw M, Bell R, Dang C. Epirubicin: is it like doxorubicin in breast cancer? A clinical review. Breast 2012;21(2):142-9.##Yao N, Fu Y, Chen L, Liu Z, He J, Zhu Y, et al. Long non-coding RNA NONHSAT101069 promotes epirubicin resistance, migration, and invasion of breast cancer cells through NONHSAT101069/miR-129-5p/Twist1 axis. Oncogene 2019;38(47):7216-33. ##Moradi Monfared M, Alizadeh Zarei M, Rafiei Dehbidi G, Behzad Behbahani A, Arabsolghar R, Takhshid MA. NDRG2 regulates the expression of genes involved in epithelial mesenchymal transition of prostate cancer cells. Iran J Med Sci 2019;44(2):118-26. ##Shamshirian A, Heydari K, Shams Z, Aref AR, Shamshirian D, Tamtaji OR, et al. Breast cancer risk factors in Iran: a systematic review &amp; meta-analysis. Horm Mol Biol Clin Investig 2020;41(4). ##Baek HS, Park N, Kwon YJ, Ye DJ, Shin S, Chun YJ. Annexin A5 suppresses cyclooxygenase-2 expression by downregulating the protein kinase C-ζ-nuclear factor-κB signaling pathway in prostate cancer cells. Oncotarget 2017;8(43):74263-75. ##Jeong JJ, Park N, Kwon YJ, Ye DJ, Moon A, Chun YJ. Role of annexin A5 in cisplatin-induced toxicity in renal cells: molecular mechanism of apoptosis. J Biol Chem 2014;289(4):2469-81. ##Xiong J, Fan F, Zhang Y, Chen W, Mao W. Epirubicin inhibits proliferation of breast cancer cells through upregulating p21cip1 expression. Int J Clin Exp Med 2016;9(11):22764-72.##Park S. Mechanical alteration associated with chemotherapeutic resistance of breast cancer cells. J Cancer Prev 2018;23(2):87-92. ##Wu Y, Zhang Y, Zhang W, Sun C, Wu J, Tang J. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles. Colloids Surf B Biointerfaces 2016;138:60-9. ##Park N, Chun YJ. Auranofin promotes mitochondrial apoptosis by inducing annexin A5 expression and translocation in human prostate cancer cells. J Toxicol Environ Health A 2014;77(22-24):1467-76.##Li X, Ma W, Wang X, Ci Y, Zhao Y. Annexin A5 overexpression might suppress proliferation and metastasis of human uterine cervical carcinoma cells. Cancer Biomark 2018;23(1):23-32.##Ea H, Monceau V, Camors E, Cohen-Solal M, Charlemagne D, Liot&#233; F. Annexin 5 overexpression increased articular chondrocyte apoptosis induced by basic calcium phosphate crystals. Ann Rheum Dis 2008;67(11):1617-25.##Kwon Y-J, Jung J-J, Park N-H, Ye D-J, Kim D, Moon A, et al. Annexin A5 as a new potential biomarker for cisplatin-induced toxicity in human kidney epithelial cells. Biomol Ther (Seoul) 2013;21(3):190-5.##Dubois T, MIRA J-P, Feliers D, Solito E, Russo-Marie F, OUDINET J-P. Annexin V inhibits protein kinase C activity via a mechanism of phospholipid sequestration. Biochem J 1998;330(Pt 3):1277-82. ##Tang J, Qin Z, Han P, Wang W, Yang C, Xu Z, et al. High Annexin A5 expression promotes tumor progression and poor prognosis in renal cell carcinoma. Int J Oncol 2017;50(5):1839-47. ##Hashemi Goradel N, Najafi M, Salehi E, Farhood B, Mortezaee K. Cyclooxygenase-2 in cancer: A review. J Cell Physiol 2019;234(5):5683-99.##Baek H-S, Park N, Kwon Y-J, Ye D-J, Shin S, Chun Y-J. Annexin A5 suppresses cyclooxygenase-2 expression by downregulating the protein kinase C-ζ–nuclear factor-κB signaling pathway in prostate cancer cells. Oncotarget 2017;8(43):74263-75.##</REF>
        </REFRENCE>
    </REFRENCES>
</ARTICLE>

<ARTICLE>
    <TitleE>Extracellular L-Asparaginase Synthesis Bacillus niacin Isolation, Optimization, and Characterization from Marine Saltern Sediment Sources</TitleE>
    <TitleF></TitleF>
    <TitleLang_ID>2</TitleLang_ID>
    <ABSTRACTS>

        <ABSTRACT>
            <Language_ID>2</Language_ID>
            <CONTENT>&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Background:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; Asparagine is an amino acid that can be converted into aspartic acid and ammonia by the enzyme L-asparaginase. Some forms of cancer, such Acute Lymphoblastic Leukaemia (ALL) and Non-Hodgkin Lymphoma (NHL), respond well to this enzyme when employed as a chemotherapeutic drug. The purpose of this research was to find bacteria that can manufacture the enzymes L-asparaginasein marine slattern sediment which can be employed in commercial and industrial scale production. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Methods:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; All of the strains were identified as &lt;em&gt;Bacillus &lt;/em&gt;&lt;/span&gt;&lt;em&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;niacini&lt;/span&gt;&lt;/em&gt;&lt;em&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; spp&lt;/span&gt;&lt;/em&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;. by biochemical and molecular testing. The strain belongs to the &lt;em&gt;Bacillus&lt;/em&gt; genus, according to nutritional, biochemical, PCR and 16srRNA sequencing data. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Results:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; According to the findings of this research, &lt;em&gt;Bacillus niacin spp.&lt;/em&gt; have the potential to create a substance that is helpful in a variety of medical applications. The results of this study hint to the possibility that bacteria have the ability to produce antimicrobial compounds, which have the potential to be successful in a wide variety of environments.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Conclusion:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; Numerous opportunities may arise for researchers interested in utilizing the medical potential of enzyme-producing bacteria if they are successfully isolated and screened from aquatic and terrestrial habitats. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
</CONTENT>
        </ABSTRACT>
    </ABSTRACTS>
    <PAGES>
        <PAGE>
            <FPAGE>40</FPAGE>
            <TPAGE>48</TPAGE>
        </PAGE>
    </PAGES>
    <AUTHORS>
        <AUTHOR>
<Name>Mugip Rahaman</Name>
<MidName></MidName>
<Family>Abdul Wahab </Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Biotechnology, Dr. M.G.R Educational and Research Institute</Organization>
</Organizations>
<Universities>
<University>Department of Biotechnology, Dr. M.G.R Educational and Research Institute</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Thirunavukkarasu</Name>
<MidName></MidName>
<Family>Palaniyandi </Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Anatomy, Biomedical Research Unit and Laboratory Animal Centre, Saveetha Dental College and     Hospital, Saveetha Institute of Medical and Technical Science, Saveetha University</Organization>
</Organizations>
<Universities>
<University>Department of Anatomy, Biomedical Research Unit and Laboratory Animal Centre, Saveetha Dental College and     Hospital, Saveetha Institute of Medical and Technical Science, Saveetha University</University>
</Universities>
<Countries>
<Country>India</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>John</Name>
<MidName></MidName>
<Family>Wyson </Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Food Processing Technology, AMET University, Kanathur</Organization>
</Organizations>
<Universities>
<University>Department of Food Processing Technology, AMET University, Kanathur</University>
</Universities>
<Countries>
<Country>India</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Asha</Name>
<MidName></MidName>
<Family>Sivaji</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Biochemistry, DKM College for Women, Vellore-632001</Organization>
</Organizations>
<Universities>
<University>Department of Biochemistry, DKM College for Women, Vellore-632001</University>
</Universities>
<Countries>
<Country>India</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Swarnakala</Name>
<MidName></MidName>
<Family>Thamada</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Molecular Systematics Laboratory, Zoological Survey of India, Andaman &amp; Nicobar Regional Centre</Organization>
</Organizations>
<Universities>
<University>Molecular Systematics Laboratory, Zoological Survey of India, Andaman &amp; Nicobar Regional Centre</University>
</Universities>
<Countries>
<Country>Andaman and Nicobar Islands</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR>
    </AUTHORS>
    <KEYWORDS>
        <KEYWORD><KeyText>Asparagine</KeyText></KEYWORD><KEYWORD><KeyText>Asparaginase</KeyText></KEYWORD><KEYWORD><KeyText>Bacillus niacini</KeyText></KEYWORD><KEYWORD><KeyText>Polymerase chain reaction </KeyText></KEYWORD>
    </KEYWORDS>
    <PDFFileName>60565.pdf</PDFFileName>
    <REFRENCES>
        <REFRENCE>
            <REF>Castro D, Marques AS, Almeida MR, de Paiva GB, Bento HB, Pedrolli DB, et al. L-asparaginase production review: bioprocess design and biochemical characteristics. Appl Microbiol Biotechnol 2021;105(11):4515-34. ##Huang D, Wang Y, Thompson JW, Yin T, Alexander PB, Qin D, et al. Cancer-cell-derived GABA promotes β-catenin-mediated tumour growth and immunosuppression. Nat Cell Biol 2022;24(2):230-41. ##Suresh SA, Ethiraj S, Rajnish KN. A systematic review of recent trends in research on therapeutically significant l-asparaginase and acute lymphoblastic leukemia. Mol Biol Rep 2022;49(12):11281-7. ##Patel PG, Panseriya HZ, Vala AK, Dave BP, Gosai HB. Exploring current scenario and developments in the field of microbial L-asparaginase production and applications: A review. Process Biochemistry 2022;121:529-41. ##Chinmayee CV, Martin A, Kumar BG, Singh SA. A new thermostable rhizopuspepsin: Purification and biochemical characterisation. Process Biochemistry 2022;1(12):18-26. ##Egler RA, Ahuja SP, Matloub Y. L-asparaginase in the treatment of patients with acute lymphoblastic leukemia. J Pharmacol Pharmacother (2016);7(2):62-71. ##Song JH, Murphy RJ, Narayan R, Davies GB. Biodegradable and compostable alternatives to conventional plastics. Philos Trans R Soc Lond B Biol Sci 2009; 364(1526):2127-39. ##Siro G, Pipite A, Christi K, Srinivasan S, Subramani R. Marine actinomycetes associated with stony corals: A potential hotspot for specialized metabolites. Microorganisms 2022;10(7):1349. ##Darvishi F, Jahanafrooz Z, Mokhtarzadeh A. Microbial L-asparaginase as a promising enzyme for treatment of various cancers. Appl Microbiol Biotechnol 2022;106(17):5335-47. ##Anand U, Carpena M, Kowalska-G&#243;ralska M, Garcia-Perez P, Sunita K, Bontempi E, et al. Safer plant-based nanoparticles for combating antibiotic resistance in bacteria: A comprehensive review on its potential applications, recent advances, and future perspective. Sci Total Environ 2022;821:153472. ##Arumugam N, Thangavelu P. Purification and anticancer activity of glutaminase and urease free intracellular l-asparaginase from Chaetomium sp. Protein Expr Purif 2022;190:106006. ##Moguel IS, Yamakawa CK, Pessoa Jr A, Mussatto SI. L-asparaginase production by Leucosporidiumscottii in a bench-scale bioreactor with co-production of lipids. Front Bioeng Biotechnol 2020;8:576511.##Ghorbanzadeh N, Ghanbari Z, Farhangi MB, Rad MK. Zinc bioremediation in soil by two isolated L-asparaginase and urease producing bacteria strains. Applied Geochemistry (2022);140):105271. ##Safrhansova L, Hlozkova K, Starkova J. Targeting amino acid metabolism in cancer. Int Rev Cell Mol Biol 2022;3(73):37-79.##Jagadeesan Y, Meenakshisundaram S, Saravanan V, Balaiah A. Greener and sustainable biovalorization of poultry waste into peptone via Bacto-enzymatic digestion: a breakthrough chemical-free bioeconomy waste management approach. Waste and Biomass Valorization 2022;13(7):3197-219. ##Mahendran S, Sankaralingam S, Tamilarasi S, Maheswari P, Kathiresan D, Ramya SS, et al. Bioactive potential of invertase by yeast Saccharomyces cerevisiae from the honey bee gut: isolation and characterization. Biomass Conversion and Biorefinery 2022;14(5):1-10. ##Saeed S, Firyal S, Tayyab M, Irfan M, Mohyud Din A, Mehmood T. Bioconversion of apple peels (Malusdomestica) to polyhydroxybutyrate using statistical design to optimize process parameters through Bacillus thuringiensis via solid-state fermentation. Biomass Conversion and Biorefinery 2022;17(8):1-9. ##Moreira DC. RGBradford: Accurate measurement of protein concentration using a smartphone camera and the blue to green intensity ratio. Anal Biochem 2022; 655:114839. ##Zhang J, Li F, Wang R, Tan X, Hagedoorn PL. Dialysis membrane enclosed laccase catalysis combines a controlled conversion rate and recyclability without enzyme immobilization. AMB Express 2020;10(1):19. ##Hern&#225;ndez-Guevara E, Guti&#233;rrez-Pabello JA, Quintero-Ch&#225;vez K, Brito-Perea MDC, Hurtado-Ayala LA, Ibarra-Molina G, et al. In silico and in vitro analysis of MAP3773c protein from Mycobacterium avium subsp. Paratuberculosis. Biology (Basel) 2022;11(8):1183. ##Zhang W, Li J, Zhang Y, Wu X, Zhou Z, Huang Y, et al. Characterization of a novel glyphosate-degrading bacterial species, Chryseobacterium sp. Y16C, and evaluation of its effects on microbial communities in glyphosate-contaminated soil. J Hazard Mater (2022;432:128689. ##Pawlowski J, Bruce K, Panksep K, Aguirre FI, Amalfitano S, Apoth&#233;loz-Perret-Gentil L, et al. Environmental DNA metabarcoding for benthic monitoring: A review of sediment sampling and DNA extraction methods. Science of the Total Environment 2022;8(18):151783.##Lorenz TC. Polymerase chain reaction: basic protocol plus troubleshooting and optimization strategies. J Vis Exp 2012;(63):e3998. ##Anahtar MN, Bowman BA, Kwon DS. Efficient nucleic acid extraction and 16S rRNA gene sequencing for bacterial community characterization. J Vis Exp 2016;(110):53939. ##Klassert TE, Zubiria-Barrera C, Neubert R, Stock M, Schneegans A, L&#243;pez M, et al. Comparative analysis of surface sanitization protocols on the bacterial community structures in the hospital environment. Clin Microbiol Infect 2022;28(8):1105-12. ##Lajevardy SA, Kargari M. Developing new genetic algorithm based on integer programming for multiple sequence alignment. Soft Computing 2022;26(8):3863-70. ##Mahadani AK, Awasthi S, Sanyal G, Bhattacharjee P, Pippal S. Indel-K2P: a modified Kimura 2 Parameters (K2P) model to incorporate insertion and deletion (Indel) information in phylogenetic analysis. Cyber-Physical Systems 2022;8(1):32-44.##Zhao Y, Qin Q, Chen L, Long Y, Song N, Jiang H, et al. Characterization and phylogenetic analysis of multiple C2 domain and transmembrane region proteins in maize. BMC Plant Biol 2022 Aug 3;22(1):388. ##Hamdi S, Allala F, Mechri S, Bouacem K, Rekik H, Hacene H, et al. Biochemical and molecular characterization of a new heme peroxidase from Aspergillus niger CTM10002, and its application in textile reactive dye decolorization. Process Biochemistry 2022;121:619-34. ##</REF>
        </REFRENCE>
    </REFRENCES>
</ARTICLE>

<ARTICLE>
    <TitleE>Anti-Quorum Sensing and Anti-Biofilm Activity of Ginger (Zingiber officinale) Rhizomes against Multidrug-Resistant Clinical Isolates of Pseudomonas aeruginosa</TitleE>
    <TitleF></TitleF>
    <TitleLang_ID>2</TitleLang_ID>
    <ABSTRACTS>

        <ABSTRACT>
            <Language_ID>2</Language_ID>
            <CONTENT>&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Background:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; The aim of this study was to determination of Anti-Quorum Sensing (AQS) and anti-biofilm potential of the methanol extract of ginger (&lt;em&gt;Zingiber officinale&lt;/em&gt;) rhizomes against multidrug-resistant clinical isolates of &lt;em&gt;&lt;span style=&quot;background-color:white&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;Pseudomonas aeruginosa&lt;/span&gt;&lt;/span&gt;&lt;/em&gt;&lt;em&gt; &lt;/em&gt;(&lt;em&gt;P. aeruginosa&lt;/em&gt;). &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Methods:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; The AQS activity of ginger was determined against &lt;em&gt;Chromobacterium violaceum&lt;/em&gt; (&lt;em&gt;C. violaceum&lt;/em&gt;) ATCC 12472 (CV12472), a biosensor strain, in qualitative manner using the agar well diffusion method. The violacein pigment inhibition was assessed to confirm AQS activity of ginger. The AQS potential of sub-minimum Inhibitory Concentrations (sub-MICs) of the ginger extract was determined by targeting different QS regulated virulence factors, including swarming motility (using swarm diameter measurement method), pyocyanin pigment (using chloroform extraction method), Exopolysaccharide (EPS) (using phenol-sulphuric acid method), and biofilm formation (using microtiter plate assay), against clinical isolates (CIs 2, 3, and 4) and standard reference strain of &lt;em&gt;P. aeruginosa &lt;/em&gt;(PA01).&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Results:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; The AQS activity of methanol extract of ginger was confirmed against &lt;em&gt;C. violaceum&lt;/em&gt; (CV12472) as inhibition of violacein pigment formation without effecting the growth of CIs and PA01 of &lt;em&gt;P. aeruginosa&lt;/em&gt;. The ginger extract exhibited concentration-dependent inhibition of virulence factors and biofilm formation. The maximum reduction was found in swarming motility, pyocyanin, EPS and biofilm formation against PA01 (51.38%), CI3 (57.91%), PA01 (63.29%) and CI2 (64.37%), respectively at 1/2 MIC of ginger extract. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Conclusion:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; The results of present study revealed the effective AQS and anti-biofilm potential of &lt;em&gt;Zingiber officinale&lt;/em&gt; rhizome methanol extract at a reduced dose (sub-MICs). The extract may be explored &lt;span style=&quot;color:black&quot;&gt;as an agent of antimicrobial compounds having AQS and anti-biofilm activity for controlling microbial infection &lt;/span&gt;and also for reducing the chances of emergence of resistance in &lt;em&gt;P. aeruginosa. &lt;/em&gt;&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
</CONTENT>
        </ABSTRACT>
    </ABSTRACTS>
    <PAGES>
        <PAGE>
            <FPAGE>49</FPAGE>
            <TPAGE>56</TPAGE>
        </PAGE>
    </PAGES>
    <AUTHORS>
        <AUTHOR>
<Name>Pankaj</Name>
<MidName></MidName>
<Family>Kumar Sagar </Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Microbiology, Bundelkhand University, Jhansi-284128</Organization>
</Organizations>
<Universities>
<University>Department of Microbiology, Bundelkhand University, Jhansi-284128</University>
</Universities>
<Countries>
<Country>India</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Poonam</Name>
<MidName></MidName>
<Family>Sharma </Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Zoology, Indira Gandhi National Tribal University (A Central University), Amarkantak-484886     </Organization>
</Organizations>
<Universities>
<University>Department of Zoology, Indira Gandhi National Tribal University (A Central University), Amarkantak-484886     </University>
</Universities>
<Countries>
<Country>India</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Rambir</Name>
<MidName></MidName>
<Family>Singh</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization></Organization>
</Organizations>
<Universities>
<University></University>
</Universities>
<Countries>
<Country></Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR>
    </AUTHORS>
    <KEYWORDS>
        <KEYWORD><KeyText>Chromobacterium violaceum</KeyText></KEYWORD><KEYWORD><KeyText>Ginger</KeyText></KEYWORD><KEYWORD><KeyText>Pseudomonas aeruginosa</KeyText></KEYWORD><KEYWORD><KeyText>Pyocyanin</KeyText></KEYWORD><KEYWORD><KeyText>Rhizome</KeyText></KEYWORD>
    </KEYWORDS>
    <PDFFileName>60566.pdf</PDFFileName>
    <REFRENCES>
        <REFRENCE>
            <REF>Boyle EM, Ainsworth JR, Levin AV, Campbell AN, Watkinson M. Ophthalmic Pseudomonas infection in infancy. Arch Dis Child Fetal Neonatal Ed 2001;85(2):F139-40. ##Chastre J, Fragon J-Y. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002;165(7):867-903. ##Rossolini GM, Mantengoli E. Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa. Clin Microbiol Infect 2005;11(Suppl 4):17-32. ##Gomez MI, Prince A. Opportunistic infections in lung diseases; Pseudomonas infections in cystic fibrosis. Curr Opin Pharmacol 2007;7(3):244-251. ##Bassetti M, Vena A, Croxatto A, Righi E, Guery B. How to manage Pseudomonas aeruginosa infections. Drugs Context 2018;7:212527.##Adonizio A, Kong KF, Mathee K. Inhibition of quorum sensing-controlled virulence factor production in Pseudomonas aeruginosa by South Florida plant extracts. Antimicrob Agents Chemother 2008;52(1):198-203. ##Hentzer M, Givskov M, Parsek MR. Targeting quorum sensing for treatment of chronic bacterial biofilm infections. Lab Med 2002a;33:295-306.##Dandekar AA, Chugani S, Greenberg EP. Bacterial quorum sensing and metabolic incentives to cooperate. Science 2012;338(6104):264-6. ##Schuster M, Greenberg EP. A network of networks: quorum sensing gene regulation in Pseudomonas aeruginosa. Int J Med Microbiol 2006;296(2-3):73-81. ##de Kievit TR. Quorum sensing in Pseudomonas aeruginosa biofilms. Environ Microbiol 2009;11(2):279–88. ##Favre-Bont&#233; S, K&#246;hler T, Van Delden C. Biofilm formation by Pseudomonas aeruginosa: role of the C4-HSL cell-to-cell signal and inhibition by azithromycin. J Antimicrob Chemother 2003;52(4):598-604. ##Venturi V. Regulation of quorum sensing in Pseudomonas. FEMS Microbiol Rev 2006;30(2):274-91.##Pesci EC, Milbank JB, Pearson JP, McKnight S, Kende SA, Greenberg EP, et al. Quinolone signaling in the cell-to-cell communication system of Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. USA 1999;96(20):11229–11234. ##Whitehead NA, Barnard AM, Slater H, Simpson NJ, Salmond GP. Quorum sensing in Gram-negative bacteria. FEMS Microbiol Rev 2001;25(4):365-404. ##Lyczak JB, Cannon CL, Pier GB. Lung infections associated with cystic fibrosis. Clin Microbiol Rev 2002;15(2):194-222. ##Vetrivel A, Ramasamy M, Vetrivel P, Natchimuthu S, Arunachalam S, Kim GS, et al. Pseudomonas aeruginosa bioﬁlm formation and its control. Biologics 2021;1(3):312-36.##Livermore DM. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?, Clin Infect Dis 2002;34 (5):634-40. ##Flamm RK, Weaver MK, Thornsberry C, Jones ME, Karlowsky JA, Sahm DF. Factors associated with relative rates of antibiotic resistance in Pseudomonas aeruginosa isolates tested in clinical laboratories in the United States from 1999 to 2002. Antimicrob Agents Chemother 2004;48(7):2431-6. ##Fankham A, Kuete V, Voukeng I, Kuiate J, Page J. Antibacterial activities of selected Cameroonian species and their synergistic effects with antibiotics against multi-drug resistant phenotypes. BMC Complem Alter Med 2011;11:104. ##Nurtjahja-Tjendraputra E, Ammit AJ, Roufogalis BD, Tran VH, Duke CC. Effective anti-platelet and COX-1 enzyme inhibitors from pungent constituents of ginger. Thromb Res 2003;111(4-5):259-65. ##Chrubasik S, Pittler MH, Roufogalis BD. Zingiberis rhizoma: A comprehensive review on the ginger effect and efficacy profiles. Phytomedicine 2005;12(9):684-701. ##Vattem DA, Mihalik K, Crixell SH, McLean RJ. Dietary phytochemicals as quorum sensing inhibitors. Fitoterapia 2007;78(4):302-10. ##Kim HS, Park HD. Ginger extract inhibits biofilm formation by Pseudomonas aeruginosa PA14. PLoS One 2013;8(9):e76106. ##Asfour HZ. Anti-quorum sensing natural compounds. J Microsc Ultrastruct 2018;6(1):1-10. ##Unuofin JO, Masuku NP, Paimo OK, Lebelo SL. Ginger from Farmyard to Town: Nutritional and Pharmacological Applications. Front Pharmacol 2021;12:779352. ##Ali BH, Blunden G, Tanira MO, Nemmar A. Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): a review of recent research. Food Chem Toxicol. 2008;46(2):409-20.##Wail EA, Emad MA. Antibacterial activity of Ginger (Zingiber Officinale Rosc.) rhizome: A mini review. Int J Pharmacogn Chinese Med 2018;2(4):000142.##Beristain-Bauza DCS, Hern&#225;ndez-Carranza P, Soledad Cid-P&#233;rez T, &#193;vila-Sosa R, Israel Ruiz-L&#243;pez I, Ochoa-Velasco CE. Antimicrobial activity of ginger (Zingiber Oﬃcinale) and its application in food products. Food Reviews International 2019;35;407-26. ##Sagar PK, Sharma P, Singh R. Antibacterial efficacy of different combinations of clove, eucalyptus, ginger, and selected antibiotics against clinical isolates of Pseudomonas aeruginosa. Ayu 2020;41(2):123-9. ##Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard. 9th ed. Wayne: CLSI; 2012.##Zahin M, Hasan S, Aqil F, Khan MS, Husain FM, Ahmad I. Screening of certain medicinal plants from India for their anti-quorum sensing activity. Indian J Exp Biol 2010;48(12):1219-24.##Sagar PK, Sharma P, Singh R. Inhibition of quorum sensing regulated virulence factors and biofilm formation by eucalyptus globulus against multidrug-resistant Pseudomonas aeruginosa. J Pharmacopuncture. 2022;25(1):37-45. ##Bala A, Kumar R, Harjai K. Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections. J Med Microbiol 2011;60 (Pt 3):300-06.##Essar DW, Eberly L, Hadero A, Crawford IP. Identification and characterization of genes for a second anthranilate synthase in Pseudomonas aeruginosa: interchangeability of the two anthranilate synthases and evolutionary implications. J Bacteriol 1990;172(2):884-900.  ##Huston AL, Methe B, Deming JW. Purification, characterization, and sequencing of an extracellular cold-active aminopeptidase produced by marine psychrophile Colwellia psychrerythraea strain 34H. Appl Environ Microbiol 2004;70(6):3321-8. ##Dubois M, Gilles KA, Hamilton JK, Rebers PA, Smith F. Colorimetric method for determination of sugars and related substances. Anal Chem 1956;28(3):350-6.##O’Toole GA, Kolter R. Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Mol Microbiol 1998;28(3):449-61. ##Sagar PK, Singh R. Anti-quorum sensing activity of clove (Syzygium aromaticum) bud extract and its combined efficacy with ceftazidime against multidrug-resistant Pseudomonas aeruginosa. Research Journal of Biotechnology 2021;16(3):75-82.##Samreen, Qais FA, Ahmad I. Anti-quorum sensing and biofilm inhibitory effect of some medicinal plants against gram-negative bacterial pathogens: in vitro and in silico investigations. Heliyon 2022;8(10):e11113. ##Sankar Ganesh P, Ravishankar Rai V. Attenuation of quorumsensing-dependent virulence factors and biofilm formation by medicinal plants against antibiotic resistant Pseudomonas aeruginosa. J Tradit Complement Med 2017;8(1):170-7. ##Tamfu AN, Ceylan O, Kucukaydin S, Ozturk M, Duru ME, Dinica RM. Antibiofilm and enzyme inhibitory potentials of two annonaceous food spices, african pepper (Xylopia aethiopica) and african nutmeg (Monodora myristica). Foods 2020;9(12):1768. ##El-Sayed NR, Samir R, Jamil M Abdel-Hafez L, Ramadan MA. Olive leaf extract modulates quorum sensing genes and biofilm formation in multi-drug resistant Pseudomonas aeruginosa. Antibiotics (Basel) 2020;9(9):526. ##Watnick PI, Kolter R. Steps in the development of a Vibrio cholerae El Tor biofilm. Mol Microbiol 1999;34(3):586-95. ##K&#246;hler T, Curty LK, Barja F, van Delden C, Pech&#232;re JC. Swarming of Pseudomonas aeruginosa is dependent on cell-to-cell signaling and requires flagella and pili. J Bacteriol 2000;182(21):5990-6.##Chen L, Wen YM. The role of bacterial biofilm in persistent infections and control strategies. Int J Oral Sci 2011;3(2):66-73. ##Nikolić M, Vasić S, Đurđević j, Stefanović O, Čomić L. Antibacterial and anti-biofilm activity of ginger (Zingiber officinale (roscoe)) ethanolic extract. Kragujevac J Sci 2014;36:129-36.##Yahya MFZR, Saifuddin NFHA, Hamid UMA. Zingiber officinale ethanolic extract inhibits formation of Pseudomonas aeruginosa biofilm. International Journal of Pharmacy and Biological Sciences 2013;3(1):46-54.##Miari M, Rasheed SS, Haidar Ahmad N, Itani D, Abou Fayad A, Matar GM. Natural products and polysorbates: Potential inhibitors of biofilm formation in Pseudomonas aeruginosa. J Infect Dev Ctries 2020;14(6):580-8. ##Akbari S, Didar Z, Vazifedoost M, Hajirostamloo B, Mohtashami M. Antibiofilm activity of ginger (Zingiber officinale) extracts in vitro and food model. Journal of Food Processing and Preservation 2023: Article ID 5134332.##Bjarnsholt T, Jensen P&#216;, Rasmussen TB, Christophersen L, Calum H, Hentzer M, et al. Garlic blocks quorum sensing and promotes rapid clearing of pulmonary Pseudomonas aeruginosa infections. Microbiology 2005;151(Pt 12):3873-880. ##Khan MS, Zahin M, Hasan S, Husain FM, Ahmad I. Inhibition of quorum sensing regulated bacterial functions by plant essential oils with special reference to clove oil. Lett Appl Microbiol 2009;49(3):354-60.  ##Husain FM, Ahmad I, Asif M, Tahseen Q. Influence of clove oil on certain quorum-sensing-regulated functions and biofilm of Pseudomonas aeruginosa and Aeromonas hydrophila. J Biosci 2013;38(5):835-44. ##</REF>
        </REFRENCE>
    </REFRENCES>
</ARTICLE>

<ARTICLE>
    <TitleE>Green Tea Extract Reduced Lipopolysaccharide-Induced Inflammation in L2 Cells as Acute Respiratory Distress Syndrome Model Through Genes and Cytokine Pro-Inflammatory</TitleE>
    <TitleF></TitleF>
    <TitleLang_ID>2</TitleLang_ID>
    <ABSTRACTS>

        <ABSTRACT>
            <Language_ID>2</Language_ID>
            <CONTENT>&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Background:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; Acute Respiratory Distress Syndrome (ARDS) is a severe lung inflammatory condition that has the capacity to impair gas exchange and lead to hypoxemia. This condition is found to have been one of the most prevalent in patients of COVID-19 with a more serious condition. Green tea (&lt;em&gt;Camellia sinensis L.&lt;/em&gt;) contains polyphenols that possess many health benefits. The purpose of this study was to assess the anti-inflammatory activities of green tea extract in Lipopolysaccharide (LPS)-induced lung cells as ARDS cells model. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Methods:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; In this study, rat lung cells (L2) were induced by LPS to mimic the inflammation observed in ARDS and later treated with green tea extract. Pro-inflammatory cytokines such as Interleukin (IL)-12, C-Reactive Protein (CRP) as well as Tumor Necrosis Factor-&amp;alpha; (TNF-&amp;alpha;) were investigated using the ELISA method. Gene expression of NOD-Like Receptor Protein 3 (&lt;em&gt;NLRP-3&lt;/em&gt;), Receptor for Advanced Glycation End-product (RAGE), Toll-like Receptor-4 (&lt;em&gt;TLR-4&lt;/em&gt;), and Nuclear Factor-kappa B (&lt;em&gt;NF-&amp;kappa;B&lt;/em&gt;) were evaluated by qRTPCR. Apoptotic cells were measured using flow cytometry. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Results:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; The results showed that green tea extract treatment can reduce inflammation by suppressing gene expressions of &lt;em&gt;NF-&amp;kappa;B, NLRP-3, TLR-4&lt;/em&gt;, and &lt;em&gt;RAGE&lt;/em&gt;, as well as pro-inflammatory cytokines such as IL-12, TNF-&amp;alpha;, and CRP, an acute phase protein. Apoptosis levels of inflamed cells also found to be lowered when green tea extract was administered; thus, also increasing live cells compared to non-treated cells. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Conclusion:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; These findings could lead to the future development of supplements from green tea to help alleviate ARDS symptoms, especially during critical moments such as the current pandemic.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
</CONTENT>
        </ABSTRACT>
    </ABSTRACTS>
    <PAGES>
        <PAGE>
            <FPAGE>57</FPAGE>
            <TPAGE>65</TPAGE>
        </PAGE>
    </PAGES>
    <AUTHORS>
        <AUTHOR>
<Name>Didik</Name>
<MidName></MidName>
<Family>Priyandoko </Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Biology Study Program, Faculty of Mathematics and Natural Sciences, Indonesia University of Education</Organization>
</Organizations>
<Universities>
<University>Biology Study Program, Faculty of Mathematics and Natural Sciences, Indonesia University of Education</University>
</Universities>
<Countries>
<Country>Indonesia</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Wahyu</Name>
<MidName></MidName>
<Family>Widowati</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization></Organization>
</Organizations>
<Universities>
<University></University>
</Universities>
<Countries>
<Country></Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Lenny</Name>
<MidName></MidName>
<Family>Lenny </Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Faculty of Biotechnology, Atma Jaya Catholic University of Indonesia, BSD Campus</Organization>
</Organizations>
<Universities>
<University>Faculty of Biotechnology, Atma Jaya Catholic University of Indonesia, BSD Campus</University>
</Universities>
<Countries>
<Country>Indonesia</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Sintya</Name>
<MidName></MidName>
<Family>Novianti</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Faculty of Biotechnology, Atma Jaya Catholic University of Indonesia, BSD Campus</Organization>
</Organizations>
<Universities>
<University>Faculty of Biotechnology, Atma Jaya Catholic University of Indonesia, BSD Campus</University>
</Universities>
<Countries>
<Country>Indonesia</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Revika</Name>
<MidName></MidName>
<Family>Revika</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Faculty of Biotechnology, Atma Jaya Catholic University of Indonesia, BSD Campus</Organization>
</Organizations>
<Universities>
<University>Faculty of Biotechnology, Atma Jaya Catholic University of Indonesia, BSD Campus</University>
</Universities>
<Countries>
<Country>Indonesia</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Hanna</Name>
<MidName></MidName>
<Family>Sari Widya Kusuma</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Biomolecular and Biomedical Research Center, Aretha Medika Utama</Organization>
</Organizations>
<Universities>
<University>Biomolecular and Biomedical Research Center, Aretha Medika Utama</University>
</Universities>
<Countries>
<Country>Indonesia</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Ika</Name>
<MidName></MidName>
<Family>Adhani Sholihah</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Biomolecular and Biomedical Research Center, Aretha Medika UtamaSchool of Life Sciences and Technology, Bandung Institute of Technology</Organization>
</Organizations>
<Universities>
<University>Biomolecular and Biomedical Research Center, Aretha Medika UtamaSchool of Life Sciences and Technology, Bandung Institute of Technology</University>
</Universities>
<Countries>
<Country>IndonesiaIndonesia</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR>
    </AUTHORS>
    <KEYWORDS>
        <KEYWORD><KeyText>Acute respiratory distress syndrome</KeyText></KEYWORD><KEYWORD><KeyText>Camellia sinensis</KeyText></KEYWORD><KEYWORD><KeyText>Cytokines</KeyText></KEYWORD><KEYWORD><KeyText>Inflammation</KeyText></KEYWORD><KEYWORD><KeyText>Tea</KeyText></KEYWORD>
    </KEYWORDS>
    <PDFFileName>60567.pdf</PDFFileName>
    <REFRENCES>
        <REFRENCE>
            <REF>Han S, Mallampalli RK. The acute respiratory distress syndrome: from mechanism to translation. J Immunol 2015;194(3):855-60. ##Ye Q, Wang B, Mao J. The pathogenesis and treatment of the ‘Cytokine Storm’in COVID-19. J Infect 2020;80(6):607-13. ##Sauer A, Peukert K, Putensen C, Bode C. Antibiotics as immunomodulators: a potential pharmacologic approach for ARDS treatment. Eur Respir Rev 2021;30(162):210093. ##Feng LH, Li XD, Zhang XY, Cheng PJ, Feng ZY. Dexamethasone for the treatment of acute respiratory distress syndrome: A systematic review and meta-analysis. Medicine (Baltimore) 2022;101(39):e30195. ##Chen R, Lan Z, Ye J, Pang L, Liu Y, Wu W, et al. Cytokine storm: the primary determinant for the pathophysiological evolution of COVID-19 deterioration. Front Immunol 2021;12(2021):589095. ##Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020;8(4):420-2.##Lingeswaran M, Goyal T, Ghosh R, Suri S, Mitra P, Misra S, et al. Inflammation, immunity and immunogenetics in COVID-19: a narrative review. Indian J Clin Biochem 2020;35(3):260-73. ##Widowati W, Darsono L, Suherman J, Fauziah N, Maesaroh M, Erawijantari PP. Anti-inflammatory effect of mangosteen (Garcinia mangostana L.) peel extract and its compounds in LPS-induced RAW264. 7 cells. Nat Prod Sci 2016;22(3):147-53.##Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol 2018;9(2018):754. ##Ohtsu A, Shibutani Y, Seno K, Iwata H, Kuwayama T, Shirasuna K. Advanced glycation end products and lipopolysaccharides stimulate interleukin‑6 secretion via the RAGE/TLR4‑NF‑κB‑ROS pathways and resveratrol attenuate these inflammatory responses in mouse macrophages. Exp Ther Med 2017;14(5):4363-70. ##Boaru SG, Borkham-Kamphorst E, Van de Leur E, Lehnen E, Liedtke C, Weiskirchen R. NLRP3 inflammasome expression is driven by NF-κB in cultured hepatocytes. Biochem Biophys Res Commun 2015;458(3):700-6. ##Danielski LG, Giustina A Della, Bonfante S, Barichello T, Petronilho F. The NLRP3 inflammasome and its role in sepsis development. Inflammation 2020;43(1):24-31. ##Pelaia C, Crimi C, Vatrella A, Tinello C, Terracciano R, Pelaia G. Molecular targets for biological therapies of severe asthma. Front Immunol 2020;11:603312. ##Carcaterra M, Caruso C. Alveolar epithelial cell type II as main target of SARS-CoV-2 virus and COVID-19 development via NF-Kb pathway deregulation: A physio-pathological theory. Med Hypotheses 2021;146:110412. ##Paudyal V, Sun S, Hussain R, Abutaleb MH, Hedima EW. Complementary and alternative medicines use in COVID-19: A global perspective on practice, policy and research. Res Soc Adm Pharm 2022;18(3):2524-8. ##Emaliyawati E, Nurhalimah H, Adha H, et al. Management of Acute Respiratory Distress Syndrome (ARDS) patients: A Literature Review. Padjadjaran Acute Care Nurs J 2021;2(2).##Leyva-L&#243;pez N, Gutierrez-Grijalva EP, Ambriz-Perez DL, Heredia JB. Flavonoids as cytokine modulators: a possible therapy for inflammation-related diseases. Int J Mol Sci 2016;17(6):921. ##Novilla A, Djamhuri DS, Nurhayati B, Rihibiha DD, Afifah E, Widowati W. Anti-inflammatory properties of oolong tea (Camellia sinensis) ethanol extract and epigallocatechin gallate in LPS-induced RAW 264.7 cells. Asian Pac J Trop Biomed 2017;(12):1005-9. ##Souza NC, de Oliveira Nascimento EN, de Oliveira IB, et al. Anti-inflammatory and antioxidant properties of blend formulated with compounds of Malpighia emarginata DC (acerola) and Camellia sinensis L.(green tea) in lipopolysaccharide-stimulated RAW 264.7 macrophages. Biomed Pharmacother 2020;128:110277. ##Saeedi-Boroujeni A, Mahmoudian-Sani M-R. Anti-inflammatory potential of Quercetin in COVID-19 treatment. J Inflamm (Lond) 2021;18(1):3. ##Hidayat M, Prahastuti S, Afifah E, Widowati W, Yusuf M, Hasan K. The role of green peas protein hydrolysate in TGF/SMAD signaling to prevent renal fibrosis. J King Saud Univ 2022;34(4):101920.##Girsang E, Ginting CN, Lister INE, Gunawan KY, Widowati W. Anti-inflammatory and antiaging properties of chlorogenic acid on UV-induced fibroblast cell. PeerJ 2021;9: e11419. ##An X, Sun X, Hou Y, Yang X, Chen H, Zhang P, et al. Protective effect of oxytocin on LPS-induced acute lung injury in mice. Sci Rep 2019;9(1):2836. ##Ngkelo A, Meja K, Yeadon M, Adcock I, Kirkham PA. LPS induced inflammatory responses in human peripheral blood mononuclear cells is mediated through NOX4 and Giα dependent PI-3kinase signalling. J Inflamm (Lond) 2012;9(1):1. ##Domscheit H, Hegeman MA, Carvalho N, Spieth PM. Molecular dynamics of lipopolysaccharide-induced lung injury in rodents. Front Physiol 2020;11:36. ##Huang Z, Kraus VB. Does lipopolysaccharide-mediated inflammation have a role in OA? Nat Rev Rheumatol 2016;12(2):123-9. ##Hawn TR, Verbon A, Janer M, Zhao LP, Beutler B, Aderem A. Toll-like receptor 4 polymorphisms are associated with resistance to Legionnaires’ disease. Proc Natl Acad Sci USA 2005;102(7):2487-9. ##Ibrahim ZA, Armour CL, Phipps S, Sukkar MB. RAGE and TLRs: relatives, friends or neighbours? Mol Immunol 2013;56(4):739-44. ##Yu J, Bi X, Yu B, Chen D. Isoflavones: anti-inflammatory benefit and possible caveats. Nutrients 2016;8(6):361. ##Kim SM, Ha JS, Han AR, Cho S-W, Yang S-J. Effects of α-lipoic acid on LPS-induced neuroinflammation and NLRP3 inflammasome activation through the regulation of BV-2 microglial cells activation. BMB Rep 2019;52(10):613-8. ##Jo E-K, Kim JK, Shin D-M, Sasakawa C. Molecular mechanisms regulating NLRP3 inflammasome activation. Cell Mol Immunol 2016;13(2):148-59. ##Freeman TL, Swartz TH. Targeting the NLRP3 inflammasome in severe COVID-19. Front Immunol 2020;11:1518. ##Yan Z, Zhong Y, Duan Y, Chen Q, Li F. Antioxidant mechanism of tea polyphenols and its impact on health benefits. Anim Nutr 2020;6(2):115-23. ##Ohishi T, Goto S, Monira P, Isemura M, Nakamura Y. Anti-inflammatory action of green tea. Antiinflamm Anti-Allergy Agents Med Chem (Formerly Curr Med Chem Anti-Allergy Agents) 2016;15(2):74-90. ##Hodges JK, Sasaki GY, Bruno RS. Anti-inflammatory activities of green tea catechins along the gut-liver axis in nonalcoholic fatty liver disease: lessons learned from preclinical and human studies. J Nutr Biochem 2020:108478. ##He W, Qu T, Yu Q, Wang Z, Lv H, Zhang J, et al. LPS induces IL‐8 expression through TLR 4, M y D 88, NF‐kappa B and MAPK pathways in human dental pulp stem cells. Int Endod J 2013;46(2):128-36. ##Noailles A, Maneu V, Campello L, Lax P, Cuenca N. Systemic inflammation induced by lipopolysaccharide aggravates inherited retinal dystrophy. Cell Death Dis 2018;9(3):350. ##Liao J, Xie X, Wang W, et al. Anti-inflammatory activity of essential oil from leaves of Blumea balsamifera (L.) DC through inhibiting TLR4/NF-kB signaling pathways and NLRP3 inflammasome activation in LPS-induced RAW264. 7 macrophage cells. Journal of Essential Oil Bearing Plants 2021;24(1):1-17.##Kelley N, Jeltema D, Duan Y, He Y. The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int J Mol Sci 2019;20(13):3328. ##Xue Y, Du M, Zhu M-J. Quercetin suppresses NLRP3 inflammasome activation in epithelial cells triggered by Escherichia coli O157:H7. Free Radic Biol Med 2017;108:760-9. ##Leu J-G, Lin C-Y, Jian J-H, Shih C-Y, Liang Y-J. Epigallocatechin-3-gallate combined with alpha lipoic acid attenuates high glucose-induced receptor for advanced glycation end products (RAGE) expression in human embryonic kidney cells. An Acad Bras Cienc 2013;85(2):745-52. ##Wang J, Fan SM, Zhang J. Epigallocatechin-3-gallate ameliorates lipopolysaccharide-induced acute lung injury by suppression of TLR4/NF-κB signaling activation. Brazilian J Med Biol Res 2019;52(7):e8092.##Bao S, Cao Y, Zhou H, Sun X, Shan Z, Teng W. Epigallocatechin gallate (EGCG) suppresses lipopolysaccharide-induced Toll-like receptor 4 (TLR4) activity via 67 kDa laminin receptor (67LR) in 3T3-L1 adipocytes. J Agric Food Chem 2015;63(10):2811-9.##Thao NP, Luyen BTT, Widowati W, Fauziah N, Maesaroh M, Herlina T, et al. Anti-inflammatory flavonoid C-Glycosides from Piper aduncum leaves. Planta Med 2016;82(17):1475-81. ##Patil KR, Mohapatra P, Patel HM, Goyal HM, Ojha SN, Kundu CN, et  al. Pentacyclic triterpenoids inhibit IKKβ mediated activation of NF-κB pathway: in silico and in vitro evidences. PLoS One 2015;10(5):e0125709. ##Paranga TG, Pavel-Tanasa M, Constantinescu D, Plesca CE, Petrovici C, Miftode I-L, et al. Comparison of C-reactive protein with distinct hyperinflammatory biomarkers in association with COVID-19 severity, mortality and SARS-CoV-2 variants. Front Immunol 2023;14:1213246. ##Salazar J, Mart&#237;nez MS, Ch&#225;vez-Castillo M, N&#250;&#241;ez V, A&#241;ez R, Torres Y, et al. C-reactive protein: an in-depth look into structure, function, and regulation. Int Sch Res Notices 2014;2014:653045. ##Semple SJ. C-reactive protein—biological functions, cardiovascular disease and physical exercise. South African Journal of Sports Medicine 2006;18:24-8.##Chen CH, Lin SW, Shen CF, Hsieh KS, Cheng CM. Biomarkers during COVID-19: mechanisms of change and implications for patient outcomes. Diagnostics (Basel) (2022) 12(2):509. ##Yang Y, Jiang G, Zhang P, Fan J. Programmed cell death and its role in inflammation. Mil Med Res 2015;2:12. ##Jiang K, Zhang T, Yin N, Ma X, Zhao G, Wu H, et al. Geraniol alleviates LPS-induced acute lung injury in mice via inhibiting inflammation and apoptosis. Oncotarget 2017;8(41):71038-53. ##Bagheri E, Hajiaghaalipour F, Nyamathulla S, Salehen N. The apoptotic effects of Brucea javanica fruit extract against HT29 cells associated with p53 upregulation and inhibition of NF-κB translocation. Drug Des Devel Ther 2018;12:657-71. ##Qi D, Wang D, Zhang C, Tang X, He J, Zhao Y, et al. Vaspin protects against LPS‑induced ARDS by inhibiting inflammation, apoptosis and reactive oxygen species generation in pulmonary endothelial cells via the Akt/GSK‑3β pathway. Int J Mol Med 2017;40(6):1803-17. ##Tang J, Diao P, Shu X, Li L, Xiong L. Quercetin and quercitrin attenuates the inflammatory response and oxidative stress in LPS-induced RAW264. 7 cells: in vitro assessment and a theoretical model. Biomed Res Int 2019;2019. ##</REF>
        </REFRENCE>
    </REFRENCES>
</ARTICLE>

    </ARTICLES>
  </JOURNAL>
</XML>
